To see the other types of publications on this topic, follow the link: Interferony (IFNy).

Dissertations / Theses on the topic 'Interferony (IFNy)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Interferony (IFNy).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Chen, Shu. "Studies on interferon (IFN) induction and isolation of IFN-inducing mutant viruses." Thesis, University of St Andrews, 2011. http://hdl.handle.net/10023/1678.

Full text
Abstract:
The interferon (IFN) system is a powerful antiviral defense system. Host cell pattern recognition receptors (PRRs) recognise pathogen-associated molecule patterns (PAMPs) which when activated, lead to the transcription of the IFN-β gene. As a consequence IFN is secreted from the cell and activates the JAK-STAT pathway to up-regulate the transcription of IFN-stimulated genes (ISGs). The products of many ISGs inhibit viral replication and cell proliferation. Viruses encode IFN antagonists that dampen down the IFN response, making it less effective. However, within a virus population, there are always likely to be naturally occurring mutant viruses that have lost the ability to circumvent the host IFN response, and if isolated, these viruses would be unlikely to cause severe disease in the host and may therefore be developed as live attenuated virus vaccine candidates. To develop a methodology to rapidly isolate IFN-inducing mutant viruses, we generated an A549 reporter cell-line in which expression of GFP was driven by the IFN-β promoter. Using this cell-line, we show that the number of cells that became positive for GFP correlated with the amount of IFN secreted by the infected cells and the number of defective interfering (DI) particles within the virus preparations. However, we were unable to isolate IFN-inducing mutant viruses using the A549/pr(IFN-β).GFP cell-line(s). Possible reasons for this may be either that, in cells infected by IFN-inducing mutant viruses, an antiviral state was established independent of IFN that prevented virus replication in the reporter cells in which the IFN-β promoter was activated; or the viruses that activated the IFN-β promoter were DIs only which were not be able to replicate without non-defective helper viruses. A549/pr(IFN-β).GFP cells are also being used for high throughput assays to screen chemical libraries for compounds that block IFN induction. Such compounds may be potential candidates for anti-inflammatory drugs.
APA, Harvard, Vancouver, ISO, and other styles
2

Walker, Angela Marie Roberts R. M. "The type I IFN of Bos taurus." Diss., Columbia, Mo. : University of Missouri-Columbia, 2008. http://hdl.handle.net/10355/6864.

Full text
Abstract:
The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from PDF of title page (University of Missouri--Columbia, viewed on April 1, 2010). Vita. Thesis advisor: R. Michaels Roberts. "May 2008" Includes bibliographical references
APA, Harvard, Vancouver, ISO, and other styles
3

Prando, Carolina Cardoso de Mello. "O papel crucial do eixo IL 12/23-IFNy para o desenvolvimento e ativação do sistema NADPH oxidase humano." [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308286.

Full text
Abstract:
Orientador: Antonio Condino Neto
Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-12T09:19:02Z (GMT). No. of bitstreams: 1 Prando_CarolinaCardosodeMello_D.pdf: 7021288 bytes, checksum: e93bf24a96be00102eb5a19f5d7c8880 (MD5) Previous issue date: 2008
Resumo: O sistema NADPH oxidase fagocítico humano possui um papel importante na defesa contra microorganismos intracelulares, incluindo micobactérias. Mutações nas subunidades deste sistema resultam na Doença Granulomatosa Crônica (DGC). O gene CYBB, localizado no cromossomo X, codifica a subunidade gp91phox, e mutações neste gene são responsáveis por cerca de 60% dos casos de DGC. Cerca de 40 anos depois da identificação de DGC, foi identificado o primeiro dos 13 defeitos genéticos associados à Susceptibilidade Mendeliana à Micobacteriose, participantes do eixo IL12/23-IFN-?. Baseado no fato de que ambas as doenças predispõem a infecções por micobactérias e que o IFN-? is é um importante ativador do gene CYBB os autores se propuseram a estudar as características clinicas de pacientes latino-americanos com DGC e o sistema NADPH oxidase e expressão do gene CYBB em pacientes com defeitos no eixo IL-12/23-IFN-?. Em relação às características clínicas: história familiar de infecções graves e/ou de repetição, bem como reação adversa à vacina BCG, linfadenopatia, abscessos de pele e profundos estavam associados à DGC, em comparação com não-DGC avaliados pelo laboratório. Defeitos nos receptores IFNGR1 e IFNGR2 e cadeia B1 do receptor de IL-12 podem apresentar expressão do gene CYBB e atividade do sistema NADPH oxidas e diminuída ou abolida, chegando a níveis comparáveis a um paciente com DGC. O IFN- ? e seus receptores são essenciais para o desenvolvimento e ativação do sistema NADPH oxidase, e pacientes com comprometimento da função deste sistema devem também ser avaliados para defeitos do eixo IL12/23-IFN-? afetando secundariamente o sistema NADPH oxidase.
Abstract: The NADPH phagocytic oxidase system plays a crucial role in host defense against intracellular microorganisms, including mycobacteria. Mutations affecting subunits of this system result in Chronic Granulomatous Disease (CGD). The CYEE gene, located in the X chromosome, encodes gp91 phox, and mutations on this gene account for more than 60% of CGD cases. Almost 40 years after, the first of 13 different genetic disorders associated with Mendelian Susceptibility to Mycobacterial Diseases (MSMD), was identified. The genes responsible for MSMD are part of the IL12/23-IFN-? axis. Based on the fact that both the diseases predispose to mycobacterial infections and that IFN-? is an important activator of CYBB gene, the authors aimed to describe clinical aspects of Latin American CGD patients and investigate ifthe NADPH oxidase system function and gp91phox expression would be affected in patients with defects in the IL-12/23-IFN-? axis. Regarding clinical features familial history of recurrent and sever infections, as well as adverse reactions to BCG vaccine, lymphadenopathy, skin and profound abscess were associated to DGC when compared to clinical features of non-CGD evaluated in the laboratory. Defects of IFNGR1 and IFNGR2 and IL12RB1 may present diminish.ed or abolished gene expression of CYBB and activity of NADPH oxidase system ate levels of a CGD patient. Based on that, we can conclude that IFN- ? and its receptor are essential for development and activation 9f NADPH oxidase system. In addition, patients who present an impaired superoxide release and/or failure on expressing gp91phox should also be evaluated for IL12/23-IFN-? axis affecting secondarily the NADPH oxidase system.
Doutorado
Doutor em Farmacologia
APA, Harvard, Vancouver, ISO, and other styles
4

Silva, Cláudia Maria de Melo. "Polimorfismos genéticos e associação com a produção de Interferon gama (IFN-y) em pacientes com Tuberculose pulmonar." Universidade Federal do Amazonas, 2014. http://tede.ufam.edu.br/handle/tede/2580.

Full text
Abstract:
Made available in DSpace on 2015-04-11T13:54:31Z (GMT). No. of bitstreams: 1 Claudia Maria de Melo Silva.pdf: 2215806 bytes, checksum: c9afeecd5c357af061e1b38a8a31df56 (MD5) Previous issue date: 2014-04-28
FAPEAM - Fundação de Amparo à Pesquisa do Estado do Amazonas
Tuberculosis (TB) is a chronic infection caused by Mycobacterium tuberculosis complex and remains a major worldwide public health problem, leading to almost 1.45 million deaths annually. The state of Amazonas has a high rate incidence of TB, about 68.3/100,000 inhabitants in 2012. Only 5 to 10% of infected individuals develop active TB. It has been suggested that host factors determine the immune response to pathogen. Thus, many immunogenetic researches have demonstrated TB associated genes, but in the north region, research in this field is still rare. This fact motivated the investigation of polymorphisms for IFNG, IL12B, CD80 and CD86 genes, which codify proteins for cellular immune response. Furthermore, IFN- concentration and its relation with genotypes found have been verified. A total of 177 patients and 224 controls (159 contacts and 65 non-contacts) were included in this study and DNA sequencing was performed for genes IFNG (SNP +874A/T and microsatellite +875), IL12B (SNPs +1030C/T, +1188A/C and +1254T/G), CD80 (SNPs -454 C/A, -387 T/C, -232 G/A, -79 C/G, -7T/C, +5C/A and an indel polymorphism -557_-561insCATGA) and CD86 (SNPs +1057G/A and +1079G/A). The IFN-y concentration was determined by enzyme-linked immunoassay. At IFNG, the presence of the allele +874A and the allele with 15 CA repeats were associated with susceptibility to pulmonary TB, while the allele +874T and the allele with 12 CA repeats were associated with protection from pulmonary TB. In addition, an association between genotype CC (SNP +1188A/C at IL12B) and increased risk of pulmonary TB was found. Furthermore, a significant difference between IFN- concentration and genotypes of SNP +1188A/C at IL12B and microsatellite at IFNG was observed, with decrease of IFN-at genotype CC and 15 CA repeats respectively. These outcomes lead to a better understanding of the immune response regulation for TB and help to determine the genetic profile of the Amazon population. Future researches are still needed for a better understanding of the role of other genes involved in the immune response to M. tuberculosis and their influence at the production of citokines like IFN-.
A Tuberculose (TB) é uma infecção crônica causada pelo complexo Mycobacterium tuberculosis sendo um importante problema de saúde pública mundial, levando a aproximadamente 1,45 milhões de mortes a cada ano. O estado do Amazonas possui uma alta incidência desta doença, atingindo 68,3 casos por 100 mil habitantes em 2012. Dos indivíduos infectados pelo bacilo, cerca de 5 a 10% desenvolvem a Tuberculose ativa, sugerindo que há fatores associados ao hospedeiro que determinam o destino da resposta imune ao patógeno. Neste contexto, diversos estudos em imunogenética têm demonstrado genes associados à TB, mas na região norte ainda são raras as pesquisas nesta área, fato que motivou a investigação da frequência dos polimorfismos nos genes IFNG, IL12B, CD80 e CD86, que codificam para proteínas fundamentais na resposta imune celular. Além disso, foi verificado se a concentração de IFN- está relacionada com o genótipo encontrado. Foram incluídas amostras de 177 pacientes e 224 controles (159 contatos e 65 não contatos) e realizado sequenciamento de DNA para os genes IFNG (SNP +874A/T e microssatélite +875), IL12B (SNPs +1030C/T, +1188A/C e +1254T/G), CD80 (SNPs -454 C/A, 454 C/A, 454 C/A, 454 C/A, -387 T/C, 387 T/C, 387 T/C, -232 G/A, 232 G/A, 232 G/A, -79 C/G, 79 C/G, 79 C/G, -7T/C e 7T/C e 7T/C e 7T/C e +5C/A+5C/A +5C/A e um polimorfismo indel -557_-561insCATGA) e CD86 (SNPs +1057G/A e +1079G/A). A determinação das concentrações de IFN-foi realizada através de ensaio imunoenzimático. Foi verificada uma associação do gene IFNG, entre a presença do alelo +874A e 15 repetições CA, como fator de risco para TB pulmonar assim como a presença do alelo +874T e 12 repetições CA como fatores de proteção contra TB pulmonar. Também foi encontrada uma associação do genótipo CC, do SNP +1188A/C no gene IL12B, como fator de risco ao desenvolvimento da TB pulmonar. Houve diferença significativa na concentração de IFN-entre os genótipos do SNP +1188A/C no gene IL12B e o microssatélite no gene IFNG, com menor produção no genótipo CC e 15 repetições CA respectivamente. Estes resultados contribuem para o melhor entendimento da regulação na resposta imune à TB e auxilia na determinação do perfil genético da população da região Amazônica. Estudos futuros são necessários para uma melhor compreensão do papel de outros genes envolvidos na resposta imunológica a M. tuberculosis e influência nos níveis de produção de citocinas como IFN-.
APA, Harvard, Vancouver, ISO, and other styles
5

Esteve-Solé, Ana. "Primary and secondary immunodeficiencies of the IL-12/IFN-γ axis." Doctoral thesis, Universitat de Barcelona, 2018. http://hdl.handle.net/10803/663924.

Full text
Abstract:
IL-12/IFN-γ axis is a principal pathway for intramacrophagic pathogens immunity such as leishmania or mycobacteria. Alterations in this axis, being both congenic (causing the primary immunodeficiency Mendelian Susceptibility to Mycobacterial Disease, MSMD) or acquired (treatment with anti-TNF-α drugs) cause susceptibility to this type of microbes. MSMD causes susceptibility mainly to non-pathogenic mycobacteria, salmonella and candida; besides, MSMD- causing mutations have been detected in Mycobacterium tuberculosis and Leishmania patients. On the other hand, the death of an anti-TNF-α in-utero exposed infant after BCG vaccination together with the effect of anti-TNF-α drugs in tuberculosis reactivation in adults and the known tole of TNF-α in B cell maturation reveal the need for an in-depth study of in-utero exposition to anti-TNF-α drugs. With that our hypothesis is that patients with extrapulmonary Mycobacterium tuberculosis infection or visceral leishmaniasis have a primary dysfunction of the IL-12/IFN-γ axis and that exposure to anti-TNF-α antibodies during whole pregnancy in children born to mothers with inflammatory bowel disease affects the normal development of the neonatal immune system, conferring a secondary immunodeficiency, which includes a dysfunction of the IL- 12/IFN-γ axis. Both extrapulmonary tuberculosis (n=23) and visceral leishmaniasis (n=24) patients presented alterations in the IL-12/IFN-γ pathway; however, we did not detect any complete defect. Concretely, the patients with extrapulmonary tuberculosis had a diminished response to IFN-γ while visceral leishmaniasis patients had a diminished production of IFN-g. Genetic study of these patients to unravel mutations causing partial forms of susceptibility to intramacrophagic infections is then needed. Besides, we detected an IL-12Rβ1 defect in a Peruvian patient that was misdiagnosed as multi-resistant tuberculosis, being a disseminated infection by the vaccine strain BCG. After the detection of the genetic defect, the patient was transferred to the National Institute of Health in the USA, where she received the appropriate treatment and the microbiological diagnosis was corrected resulting in the resolution of the infection. This case remarks the fact that suspicion of this forms of immune deficiency and their detection changes the prognostics and outcome of the patient. The study of the effect of anti-TNF-α on the exposed infant immune system (n=7) revealed a T and B cell maturation defect that was corrected at 12 months, normal cell proliferation after mitogen stimulation and normal immunoglobulin production and vaccine response without an increase of severe infections. On the other hand, Treg cell frequency was low in exposed infants, without reaching normalization at 12 months of age. Treg cell frequency in neonates inversely correlated with anti-TNF-α through level in the mother during third trimester of pregnancy and with T cell proliferation after a mild mitogen stimulation. These data with the increased atopia/allergy in the studied infants suggest the need of a long-term follow-up for Treg cells and the advent of immune dysregulation events. Antimycobacterial response was diminished in exposed infants and not totally recovered after washing the drug from the blood in the culture. On the other hand, coinciding with the decrease of the drug levels in blood, the production of IL-12, IFN-γ and TNF-α increased. We conclude that the effects of anti-TNF-α exposure during pregnancy are not permanent and that BCG vaccination in these population should be avoided until, at least, 12 months of age. By last, the transition between the intra- and extra-uterine world is a special life-situation where the immune system plays a major role. We studied it in healthy cord blood donors, with special attention to the IL-12/IFN-γ pathway and B cell compartment, including regulatory B cells (Breg). Breg cells, defined as CD24hiCD38hi B cells, were expanded in cord blood, with capacity to produce IL-10 and to inhibit IL-4 and IFN-γ production by T cells with a similar phenotype when compared with adult Bregs. Besides, response to mycobacterial challenge was diminished. Interestingly, the diminished production of IFN-γ was associated with Breg cell frequency, opening the door to new research studying the role of these cells in different neonatal conditions as well as in cord blood derived stem cell transplantation.
Esta tesis explora la vía de IL-12/IFN-g, central en la inmunidad a gérmenes intramacrofágicos, en el contexto de defectos primarios y secundarios. Los defectos primarios en esta vía causan susceptibilidad mendeliana a las micobacterias (MSMD), una inmunodeficiencia primaria que cursa con susceptibilidad a micobacterias no patogénicas principalmente, pero en la que se han descrito pacientes con infecciones por Mycobacterium tuberculosis y con leishmaniasis. En este escenario, la hemos estudiado en pacientes pediátricos con tuberculosis extrapulmonar y leishmaniasis visceral, revelando que no existían defectos completos de la vía, pero sí una alteración funcional en ésta en los dos grupos de pacientes estudiados. Esto reveló la necesidad de un estudio genético exhaustivo para revelar defectos parciales causantes de esta susceptibilidad. El diagnóstico la deficiencia de IL-12Rβ1 en una niña con infección diseminada por BCG, inicialmente diagnosticada como tuberculosis multirresistente, permitió el tratamiento adecuado que llevó a su curación, mostrando la relevancia del diagnóstico temprano del MSMD. Por otro lado, el hecho que se describiera un caso de muerte tras la vacunación con BCG de un neonato expuesto a fármacos anti-TNF-α durante el embarazo hizo pensar que la exposición a estos fármacos durante el embarazo pudiera llevar a defectos en el sistema inmunitario del neonato. Tras su estudio, observamos una inmadurez transitoria del compartimiento B y T; por otro lado, la disminución de la frecuencia de células T reguladoras que no normalizó con la edad juntamente con un aumento de la presencia de atopia o alergia en este grupo. Además, observamos una disminución de la respuesta a micobacterias en los niños expuestos, que mejoró con la edad. Concluimos que los efectos de los niños expuestos a anti-TNF-α durante el embarazo no parecen ser permanentes y que la vacunación con BCG de esta población debe ser evitada hasta los 12 meses de edad. El estudio de sangre de cordón de neonato sano reveló un aumento de la población de células B reguladoras. Además, la frecuencia de estas células se asoció inversamente con la producción de IFN-γ tras el estímulo con micobacterias, que se encontró disminuido en el neonato. Abriendo la puerta a nuevas investigaciones para estudiar su papel en diferentes condiciones del neonato, así como en el trasplante de progenitores hematopoyéticos.
APA, Harvard, Vancouver, ISO, and other styles
6

Killip, Marian J. "RNA virus modulation of IFN, PI3K and apoptosis." Thesis, St Andrews, 2009. http://hdl.handle.net/10023/777.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zurney, Jennifer Michelle. "Cardiac Cell Type-Specific Differences in the Interferon (IFN) Response, and Reovirus Repression of IFN." NCSU, 2008. http://www.lib.ncsu.edu/theses/available/etd-06302008-141954/.

Full text
Abstract:
Viral myocarditis is an important human disease associated with a wide variety of viruses. The cardiac damage and inflammation associated with viral myocarditis can be immune mediated and/or due to direct cytopathic effect. Reovirus-induced myocarditis reflects direct virus-mediated apoptosis of cardiac cells, providing an excellent model to study direct cytopathic effect in the heart. Previous work has found interferon-beta (IFN) to be an important determinant for protection against viral myocarditis. Importantly, IFN signals through the Jak-STAT pathway to induce the expression of interferon-stimulated genes (ISGs) and establish an antiviral state. First, we investigated the underlying mechanisms of the IFN response in these cardiac cells. We found that high basal IFN-beta expression in cardiac myocytes protects this vulnerable, nonreplenishable cardiac cell type, while high basal expression of interferon alpha receptor 1 and latent Jak-STAT components in adjoining cardiac fibroblasts renders these cells more responsive to IFN and prevents them from inadvertently serving as a virus reservoir. This provides the first evidence for an integrated network of cell-type-specific innate immune components for organ protection. Next, we investigated whether particular reovirus strains were able to repress IFN signaling. We found that the mildly myocarditic reovirus, T1L, but not the nonmyocarditic reovirus, T3D, could repress IFN induction of ISGs and that this repressor function is determined by the M1 gene of T1L. Infection with T1L or reassortant or recombinant viruses containing the T1L M1 gene results in accumulation of IRF9 in the nucleus; an effect not previously described for any virus. The M1 gene has also previously been identified as a determinant of virus strain-specific differences in the IFN response, and the M1 gene and the IFN response have been identified as determinants of virus strain-specific differences in induction of murine myocarditis. Here, we find that virus-induced myocarditis is associated with repression of IFN function, providing new insights into the pathophysiology of this disease. Together, these data provide the first report of an increase in IRF9 nuclear accumulation associated with viral subversion of the IFN response, and provide evidence that virus strain-specific differences in IFN antagonism are a determinant of disease.
APA, Harvard, Vancouver, ISO, and other styles
8

Antoniazzi, Alfredo Quites. "Função endócrina do interferon-tau durante o reconhecimento materno da gestação em ovinos." Universidade Federal de Santa Maria, 2010. http://repositorio.ufsm.br/handle/1/4049.

Full text
Abstract:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
The objective of the present study is to evaluate interferon-tau (IFNT) endocrine action in extra uterine tissues. The first approach consists of collecting samples from ewes on days 12, 13, 14 and 15 of the estrous cycle or early pregnancy. The second, consists of installing osmotic pumps to deliver a continuous concentration of recombinant ovine (ro) IFNT into the uterine vein for 24 or 72 hours. Our hypothesis is that endocrine release of IFNT into the uterine vein occurs as early as Day 13 of pregnancy. Also, that 24 and 72 hours infusion of roIFNT induces ISGs in the CL, liver and endometrium and IFNT has endocrine action on the CL to modulate major genes involved in luteolysis. Endometrium, liver, corpus luteum, uterine vein, jugular and uterine vein blood were collected from cyclic (NP) and pregnant (P) ewes on Days 12, 13, 14 and 15. Instalation of 24 and 72 hour pumps was done on Day 10 of the estrous cycle. Half were infused with BSA and the other half with roIFNT. Only in the 24 hour infusion, half of each group was challanged with a PGF injection at 12 hours following pump installation. Concentrations of progesterone in serum were similar on Days 12 and 13 and then declined (P<0.05) to less than 1 ng/ml in NP ewes between Days 14 and 15. Endometrial ISG15 mRNA increased (P<0.05) in P versus NP ewes by Day 13 and remained greater through Day 15. Endometrial ESR1 and OXTR mRNAs were up-regulated (P<0.05) in NP compared to P ewes by Day 14, and remained up-regulated on Day 15. Uterine vein ISG15 mRNA was not affected by pregnancy status. IFNAR1 and IFNAR2 mRNA were present in the CL, but did not change due to pregnancy status. ISG15 mRNA in CL and liver increased (P<0.05) by Day 14 and remained up-regulated on Day 15 in P compared to NP ewes. The expression of ESR1, OXTR, PTGFR, PTGER2, PTGER3 and PTGER4 did not change in the corpus luteum during Days 12, 13, 14 and 15 related to pregnancy status. Following the 24 hour infusion, ESR1, OXTR, PTGER2 and PTGER3 mRNA were not affected, but SLCO2A1 mRNA decreased (P<0.001) in BSA+PGF, roIFNT and roIFNT+PGF compared to BSA-infused ewes. PTGFR mRNA was down regulated (P<0.001) in roIFNT and roIFNT+PGF compared to BSA and BSA+PGF-infused ewes. PTGER4 mRNA was greater (P<0.05) in roIFNT and roIFNT+PGF compared to BSA, but not compared to BSA+PGF-infused ewes. After 72 hours, concentrations of progesterone did not differ in roIFNT- compared to BSA-infused ewes. ISG15 mRNA was induced in the CL, liver and endometrium in roIFNT- compared with BSA-infused ewes. Endocrine action of IFNT occurred through up-regulation of ISG15 mRNA in CL and liver by Day 14 of pregnancy. It is concluded that IFNT has endocrine effects on the CL between Days 13 and 14 of pregnancy and may protect the CL through mechanisms that are complementary, yet independent to its paracrine effects on the OXTR endometrial pathway.
O objetivo deste trabalho foi avaliar a resposta do interferon-tau (IFNT) em tecidos extra uterinos utilizando dois modelos experimentais. O primeiro, com a utilização de amostras coletadas nos dias 12, 13, 14 e 15 do ciclo estral ou da gestação e o segundo com a instalação de bombas osmóticas de infusão contínua por 24 ou 72 horas. Formulou-se a hipótese que o IFNT é liberado na veia uterina em torno do dia 13 da gestação. Também, que após 24 ou 72 horas de infusão na veia uterina, o interferon-tau é capaz de induzir a expressão de genes estimulados pelo interferon (ISGs) no corpo lúteo, fígado e endométrio. A resposta no corpo lúteo é capaz de modular genes envolvidos na luteólise. Para isso, foram coletados endométrio, corpo lúteo, fígado, veia uterina, sangue das veias jugular e uterina, nos dias 12, 13, 14 e 15 do ciclo estral ou gestação. A instalação das bombas osmóticas de infusão por 24 e 72 horas foi realizada no dia 10 do ciclo estral, onde metade dos animais receberam infusão de albumina bovina (grupo BSA) e outra metade de IFNT recombinante ovino (ro; grupo roIFNT). Nos animais infundidos por 24 horas, metade de cada grupo BSA ou roIFNT, recebeu um desafio com prostaglandina F2 alfa (PGF; grupos BSA+PGF e roIFNT + PGF) 12 horas após a instalação das bombas. Concentrações sericas de progeterona foram iguais nos dias 12 e 13, e diminuiram (P<0,05) a menos de 1 ng/ml entre os dias 14 e 15 nos animais cíclicos. A expressão de ISG15 endometrial aumentou (P<0,05) no dia 13 em ovelhas prenhes, e permaneceu elevada até o dia 15. A expressão dos receptores de estrógeno alfa (ESR1) e de ocitocina (OXTR) aumentaram (P<0,05) em ovelhas cíclicas comparadas com prenhes no dia 14, permanecendo elevadas no dia 15. A expressão de ISG15 na veia uterina não apresentou diferença em função da gestação. A expressão dos receptores de Interferon tipo I não apresentou diferença em função da prenhez no corpo lúteo. No corpo lúteo e fígado, a expressão de ISG15 aumentou no dia 14 da gestação, permanecendo no dia 15. A expressão luteal de ESR1, OXTR, receptores de PGF (PTGFR), e E2 subtipos 2 (PTGER2), 3 (PTGER3) e 4 (PTGER4) não apresentaram diferença em função da gestação nos dias 12, 13 14, e 15. Após 24 horas de infusão, a expressão luteal de ESR1, OXTR, PTGER2 e PTGER3, não apresentaram diferenças. O transportador de prostaglandinas diminuiu nos grupos BSA+PGF, roIFNT e roIFNT+PGF (P<0,001). O receptor PTGFR diminuiu a expressão (P<0,001) nos grupos roIFNT e roIFNT+PGF, e o receptor PTGER4 aumentou (P<0,05) nos grupos roIFNT e roIFNT+PGF. Em 72 horas de infusão, não foi observada diferença na secreção de progesterona. A expressão de ISG15 nos animais do grupo roIFNT aumentou (P<0,01) no corpo lúteo, fígado e endométrio. Assim, a função endócrina do IFNT ocorre com a expressão de ISG15 no dia 14 da gestação no corpo lúteo e no fígado. Portanto, a ação endócrina do IFNT acontece entre os dias 13 e 14 da gestação e pode proteger o corpo lúteo por mecanismos complementares ao mecanismo anti luteolítico parácrino endometrial.
APA, Harvard, Vancouver, ISO, and other styles
9

SANTOS, Joelma Carvalho. "Análise de polimorfismos de único nucleotíldeo (SNP) e expressão dos genes das citocinas IFN-a1, IFN-y e do receptor IFN-a r1 em relação à quantificação da carga viral em pacientes com hepatite B." Universidade Federal de Pernambuco, 2014. https://repositorio.ufpe.br/handle/123456789/11489.

Full text
Abstract:
Submitted by Marcelo Andrade Silva (marcelo.andradesilva@ufpe.br) on 2015-03-09T14:28:37Z No. of bitstreams: 2 DISSERTAÇÃO Joelma Carvalho Santos.pdf: 2064030 bytes, checksum: 9d9c233bec668a94294f6d19471cb844 (MD5) license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5)
Made available in DSpace on 2015-03-09T14:28:37Z (GMT). No. of bitstreams: 2 DISSERTAÇÃO Joelma Carvalho Santos.pdf: 2064030 bytes, checksum: 9d9c233bec668a94294f6d19471cb844 (MD5) license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) Previous issue date: 2014
A presença de polimorfismos de único nucleotídeo (SNPs) e a expressão variante dos genes das citocinas IFN-α1, IFN-γ e do receptor IFN-α r1 em pacientes com infecção crônica pelo vírus da hepatite B (HBV), podem ser considerados fatores etiopatogênicos relacionados aos níveis séricos do HBV, resultando em complicações da doença. Desta forma, o presente estudo teve como objetivo verificar a associação entre as frequências genotípicas e proporções alélicas dos genes IFNG, IFNA1, IFNAR1 em relação aos níveis de expressão desses genes e à carga viral do HBV, em pacientes com infecção crônica pelo HBV sem tratamento antiviral. Foi realizado um estudo de caso-controle com amostras de sangue total de 208 indivíduos (94 pacientes com infecção crônica e 114 indivíduos imunes ao HBV) no período de outubro de 2012 a agosto de 2013, no ambulatório de hepatologia do Hospital das Clínicas da Universidade Federal de Pernambuco (HC/UFPE) e no Hospital Escola Dr. Helvio Auto da Universidade Estadual de Ciências da Saúde de Alagoas (HEHA/UNCISAL). Para a identificação dos polimorfismos foi utilizada a PCR em tempo real (qPCR) de acordo com técnica de alta resolução de melting (HRM). A quantificação da carga viral e a expressão absoluta dos genes IFNG (-5 A>G), IFNA1 (-2 C>T), IFNAR1 (-97 T>C) foram realizadas por qPCR. Em todos os pacientes com infecção crônica pelo HBV os níveis de expressão foram menores para o gene IFNA1 (mediana=2,56x10-1ηg/μL), em relação aos genes IFNG (mediana=4,54x105ηg/μL) e IFNAR1 (mediana=6,92x109ηg/μL), e a média de carga viral foi de 3,2 log10. Pacientes com genótipo heterozigoto IFNA1(-2) CT e alelo polimórfico IFNA1 (-2) T apresentaram maiores chances de desenvolver proteção pelo HBV quando comparados a indivíduos imunes com genótipo IFNA1(-2) CC e alelo tipo selvagem C, respectivamente (IFNA1 CT/CC: OR=0,45; p=0,01 e IFNA T/C: OR=0,54; p<0,01). Em pacientes com infecção crônica e genótipo tipo selvagem TT do IFNAR1, os baixos níveis de expressão do gene desse receptor, quando comparado aos outros genótipos, explicam em 40% os altos níveis de carga viral desses pacientes (r2=0,40 | p=0,04) conferindo um risco para o desenvolvimento da cronicidade. Para o genes IFNG(-5) não foi observada diferença estatisticamente significante entre os níveis de expressão e os genótipos. Assim, a presença da variante polimórfica do gene IFNA1 (-2) em pacientes com infecção crônica, pode estar associada à proteção da cronicidade quando comparada ao grupo controle. Os altos níveis de expressão do gene IFNAR1 e baixos níveis de IFNA1 podem contribuir para a cronicidade nestes indivíduos. Os pacientes que com genótipo polimórfico IFNA1 (-2) CT e alelo T apresentaram maior proteção para a cronicidade pelo HBV.
APA, Harvard, Vancouver, ISO, and other styles
10

Chao, Ping. "Molecular basis of PKR activation by Interferon-gamma (IFNγ) mRNA 5’-UTR." Thesis, University of Manchester, 2011. https://www.research.manchester.ac.uk/portal/en/theses/molecular-basis-of-pkr-activation-by-interferongamma-ifn-mrna-5utr(76530b0e-e02f-4d59-8d38-4a2ba46fe741).html.

Full text
Abstract:
PKR is an interferon (IFN)-induced protein kinase that is activated by double-stranded RNA in a mechanism involving binding of the N-terminal domain of PKR, protein dimerization and autophosphorylation. PKR is a key component of the cellular antiviral response and plays critical roles in a variety of other cellular processes including signal transduction, growth and apoptosis. Once activated, PKR phosphorylates its substrate, translation initiation factor (eIF2) on its alpha subunit at Ser51, thereby leading to an inhibition of protein synthesis. The IFN-gamma mRNA 5’-UTR, an H-type pesudoknot structure, is also a PKR activator. Activation through this structure thus and inhibition of translation thus autoregulates of overexpression of the IFN-gamma mRNA.Herein, I present a biochemical and biophysical characterization of the interaction between PKR and IFN-gamma mRNA 5’-UTR. In vitro PKR autophosphorylation assays defined that the minimal requirement of IFN-gamma mRNA 5’-UTR domain for PKR autophosphorylation is a 120 nt fragment that also exhibits the pseudoknot conformation. Additionally, mutations to disrupt IFN-gamma mRNA pseudoknot base pairing and stability decreased the ability to induce PKR autophosphorylation. Interaction of IFN-gamma 120 RNA and PKR appears to exhibit a ~1:2 binding stoichiometry. These results show that IFN-gamma mRNA binding to PKR is in agreement with other PKR activators; binding of dsRNA to PKR promotes dimerization and autophosphorylation.
APA, Harvard, Vancouver, ISO, and other styles
11

Corbera, Bellalta Marc. "Regulació de l’activitat inflamatòria per IFN-gamma en l'Arteritis de Cèl·lules Gegants (ACG)." Doctoral thesis, Universitat de Barcelona, 2015. http://hdl.handle.net/10803/396137.

Full text
Abstract:
L'ACG és una malaltia inflamatòria crònica de caràcter granulomatós, que afecta a les arteries grans i mitjanes en pacients d’edat avançada. El tractament majoritàriament establert per l'ACG són els glucocorticoides, que malgrat produir generalment una remissió ràpida dels símptomes, no eviten rebrots, i presenten una sèrie important d’efectes secundaris que fan necessària la investigació de teràpies alternatives. La investigació de nous tractaments requereix un coneixement més acurat sobre la patogènesi de la malaltia. La fisiopatologia de la malaltia es fonamenta en hipòtesis i deduccions fetes a partir de l’observació de l’expressió de molècules que tenen funcions conegudes en altres patologies. Així doncs s’ha acceptat que l'ACG s'inicia amb la presentació d'un antigen desconegut per part de les cèl·lules dendrítiques. Això provocarà una onada inflamatòria amb activació de leucòcits, i la progressió d'un infiltrat inflamatori a través de la paret arterial desestructurant les diferents làmines, que conclou amb la hiperplàsia de la làmina íntima i la obturació de la llum del vas. L'IFN-g per la seva banda, és una citoquina implicada en multitud de fenòmens relacionats amb la inflamació, com són l'activació de macròfags, la producció de molècules d’adhesió per part de les cèl·lules endotelials, o el reforçament de la via de diferenciació limfocitària Th1. Tots aquests fenòmens semblen rellevants durant la fisiopatologia de l'ACG, però malgrat això el rol de l'IFN-g en aquesta malaltia és encara desconegut. Una de les limitacions que té la investigació en ACG, és l'absència d'un model animal que permeti la realització d'estudis funcionals. En aquest sentit, els objectius del nostre treball són la posada a punt d'un model de cultiu d'artèria que permeti avaluar els efectes de molècules bloquejants i/o fàrmacs amb finalitat terapèutica. I en segon lloc aprofundir en el paper de l'IFN-g en l'ACG, definint les funcions que pugui tenir en la fisiopatologia de la malaltia però també en el manteniment de d’infiltrat inflamatori a la paret arterial. Així doncs, hem posat a punt el model de cultiu d'artèria temporal de pacients amb ACG, comprovant que l’estructura de la paret arterial es preserva durant temps perllongats en cultiu i mantenint la viabilitat de l'infiltrat inflamatori. Aquest model ens ha permès valorar les diferències en l'expressió de molècules pro-inflamatòries i molècules involucrades en el remodelatge vascular, entre biòpsies positives i negatives, i quins efectes té el tractament amb glucocorticoides sobre l'expressió d’aquestes. Així doncs, les biòpsies de pacients amb ACG presenten nivells d'expressió més elevats de IFN-g, IL-1b, CCL3, 4 i 5, i MMP9. El tractament amb glucocorticoides disminueix l'expressió d’aquestes mateixes molècules i de IL-6, TNF-a i CXCL8, així com la presencia de macròfags (identificats mitjançant immunotinció amb CD68) a la paret arterial. En canvi els corticoides no afecten substancialment l’expressió de molècules involucrades en el remodelatge vascular com el PDGF, TGFb o col·làgens. En el segon treball hem bloquejat l'IFN-g amb un anticòs monoclonal humà, que inhibeix en les artèries l’expressió i fosforilació de Stat-1, el factor de transcripció de la via canònica de l'IFN-g. Hem vist que aquest bloqueig té un impacte significatiu sobre l’expressió de quimiocines directament induïdes per IFN-g, com CXCL9, 10 i 11, tan a nivell de mRNA com de proteïnes, i també té efectes inhibitoris sobre molècules com IL-1b o TNF-a, tot i que aquestes tendències no han arribat a ser estadísticament significatives. L’estimulació de les artèries amb IFN-g recombinant ha resultat en un augment de l’expressió d’aquestes mateixes quimiocines i també dels receptors CCR2 i CXCR3. L'IFN-g també té un efecte estimulador de l’expressió de quimiocines sobre el component cel·lular majoritari de la paret arterial, les cèl·lules musculars llises (VSMC). L'IFN-g estimula en aquest tipus cel·lular les quimiocines CXCL9, 10 i 11, i CCL2, i també les molècules d’adhesió ICAM-1 i VCAM-1, i els factors de transcripció Stat-1 i Stat-3. Aquests augments de la síntesi de quimiocines i molècules d'adhesió es tradueixen en un augment de la migració (a través de CXCR3) i de l'adhesió de limfòcits i monòcits cap a les VSMC. El contacte entre aquests tipus cel·lulars ja provoca per si mateix un increment de l'expressió de quimiocines, i aquesta estimulació desapareix a l'inhibir l'IFN-g. Així doncs, l'IFN-g sembla tenir un paper significatiu en la progressió de l'infiltrat inflamatori a través de la paret arterial. El seu alliberament per part de les cèl·lules inflamatòries provoca en les VSMCs un increment de la síntesi de molècules que provoquen la migració i l'adhesió de les pròpies cèl·lules inflamatòries. Aquests resultats proporcionen les primeres evidencies sobre el paper funcional del l’IFNg en l’arteritis de cèl·lules gegants i constitueixen un primer pas per explorar el seu potencial com a possible diana terapèutica en l'ACG.
GCA is a granulomatous vasculitis of the elderly, affecting large and medium-sized arteries. Glucocorticoids are the cornerstone of GCA treatment, but unfortunately the majority of patients experience undesirable side effects and relapse when glucocorticoids are tapered. This observation underlines the need for searching alternative therapies in GCA. Investigating new treatments requires a better understanding of GCA pathogenesis and the development of functional models for pre-clinical testing, since there are no animal models for GCA. IFN-g, highly expressed in GCA patients compared to controls, is a cytokine implicated in multiple inflammatory-related pathways, and it may contribute to GCA pathogenesis by participating in lymphocyte Th1 differentiation and by activating macrophages promoting granuloma formation. However, this is extrapolated from its known biologic functions and the functional role of IFN-g in GCA has not been explored. Our main objectives were: to develop a human temporal artery culture model for functional studies, and to explore IFN-g roles by using a neutralizing, fully human monoclonal antibody against IFN-g. In our first study we developed a temporal artery culture model in tri-dimensional matrix where viability and morphology is preserved for up to 2 weeks. In this model we have confirmed differences in expression of pro-inflammatory molecules between GCA and control arteries. We have also observed that glucocorticoids inhibit mRNA expression of pro-inflammatory cytokines such as IFN-g and IL-1b or chemokines CCL3, 4 and 5, as well as a reduction in macrophage infiltration assessed by CD68 immunostaining. Interestingly, glucocorticoids did not have a significant effect on the expression of molecules involved in vascular remodelling such as PDGF, TGFb or collagens. In the second study, we used a fully human neutralizing antibody against IFN-g in order to inhibit IFN-g effects. Treatment of cultured arteries with this antibody reduced the expression and phosphorylation of Stat-1, a pivotal transcription factor in IFN-g-driven canonical signalling pathways. IFN-g blockade led to significant decrease in mRNA and protein expression of CXCL9, 10 and 11 in cultured arteries and a decrease in infiltrating CD68 macrophages. Stimulating GCA arteries with recombinant IFN-g elicited the opposite effects. We demonstrated that IFN-g had significant effects on the main cellular component of the arterial wall, vascular smooth muscle cells (VSMC) by inducing chemokine (CXCL9, 10 and 11, and CCL2) and adhesion molecule (ICAM-1 and VCAM-1) expression. This resulted in increased PBMCs migration and adhesion to cultured VSMC and to normal arteries exposed to IFN-g. In summary, IFN-g synthetized by inflammatory cells, acts on VSMCs via Stat1, to enhance the production and secretion of chemokines and adhesion molecules that regulate trafficking of these leukocytes, perpetuating a loop that contributes to the maintenance and progression of the inflammatory infiltrates in the arterial wall. Our work provides first evidences supporting a functional role of IFNg in GCA, a necessary first step to explore its potential as therapeutic target.
APA, Harvard, Vancouver, ISO, and other styles
12

Campbell, Gillian Mhairi. "Influenza virus infection in a compromised immune system." Thesis, University of Edinburgh, 2012. http://hdl.handle.net/1842/6521.

Full text
Abstract:
Severe influenza virus infection, including human infection with highly pathogenic H5N1 viruses is characterised by massive pulmonary inflammation, immunopathology and excessive cytokine production, a process in which macrophages may play a vital role. The aim of this project was to investigate the hypothesis that inhibition of inflammatory responses from infected macrophages, using either alternatively activated bone marrow derived macrophages (BMDMf), or IFNg receptor deficient (IFNgR-/-) mice may ameliorate the devastating immunopathology and inflammation routinely observed in highly pathogenic influenza virus infections. Infection of alternatively activated BMDMf resulted in enhanced positivity for viral proteins, compared with classically activated, inflammatory BMDMf. However, neither subset propagated the infection indicating that while infection is abortive in both classical and alternatively activated BMDMf, the latter may prove more efficient at removing infectious virus from the site of infection due to enhanced infectivity. However, influenza virus was capable of driving expression of proinflammatory mediators such as iNOS and TNFa from classical and alternatively activated BMDMf even in the absence of IFNg signalling. IFNgR-/- BMDMf demonstrated a reduced inflammatory response to infection compared to Sv129 counterparts, suggesting a potentially impaired inflammatory response in vivo. This was investigated by infection of IFNgR-/- mice, which resulted in ameliorated disease, lower viral titres and mild immunopathology, demonstrating that inhibition of IFNg signalling limits the severity of disease. Additionally, mRNA expression for key inflammatory mediators was reduced, demonstrating that inhibition of the overwhelming inflammatory response to influenza virus infection is beneficial to the host, resulting in protection from immunopathology and improved prognosis, without impairing viral clearance.
APA, Harvard, Vancouver, ISO, and other styles
13

Keller, Emma Jean. "The Contribution of IFNα-Stimulated Immune Cell Populations to B6.NbA2 Lupus-likeDisease." Case Western Reserve University School of Graduate Studies / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=case1625138193480211.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Liu, Qinfang. "Interaction of type I interferons and mTOR signaling underlying PRRSV infection." Thesis, Kansas State University, 2016. http://hdl.handle.net/2097/32860.

Full text
Abstract:
Master of Science in Biomedical Sciences
Department of Anatomy and Physiology
Yongming Sang
Animal metabolic and immune systems integrate and inter-regulate to exert effective immune responses to distinct pathogens. The signaling pathway mediated by mechanistic target of rapamycin (mTOR) is critical in cellular metabolism and implicated in host antiviral responses. Recent studies highlight the significance of the mTOR signaling pathway in the interferon (IFN) response. Type I IFNs mediate host defense, particularly, against viral infections, and have myriad roles in antiviral innate and adaptive immunity. In addition to their well-known antiviral properties, type I IFNs also affect host metabolism. However, little is known about how animal type I IFN signaling coordinates immunometabolic reactions during antiviral defense. Therefore, understanding the interaction of mTOR signaling and the type I IFN system becomes increasingly important in potentiating antiviral immunity. Tissue macrophages (MФs) are a primary IFN producer during viral infection, and their polarization to different activation statuses is critical for regulation of immune and metabolic homeostasis. Using porcine reproductive and respiratory syndrome virus (PRRSV) as a model, we found that genes in the mTOR signaling pathway were regulated differently in PRRSV-infected porcine alveolar MФs at different activation statuses. Therefore we hypothesize that: 1) the mTOR signaling pathway involves host anti-PRRSV regulation; 2) mTOR signaling interacts with IFN signaling to modulate the antiviral response; and 3) different type I IFN subtypes (such as IFN-α1 and IFN-β) regulate mTOR signaling differently. We show that modulation of mTOR signaling regulated PRRSV infection in MARC-145 cells and porcine primary cells, in part, through regulating production and signaling of type I IFNs. In addition, expression and phosphorylation of two key components in the mTOR signaling pathway, AKT and p70 S6 kinase, were regulated by type I IFNs and PRRSV infection. Taken together, we determined that the mTOR signaling pathway, a key pathway in regulation of cell metabolism, also mediates the type I IFN response, a key immune response in PRRSV infection. Our findings reveal that the mTOR signaling pathway potentially has a bi-directional loop with the type I IFN system and implies that some components in the mTOR signaling pathway can serve as targets for augmentation of antiviral immunity and therapeutic designs.
APA, Harvard, Vancouver, ISO, and other styles
15

Zeer, Munir Ali al. "IFN[gamma] inducible GTPases mediate host Resistance against Chlamydia trachomatis via autophagy." Berlin mbv, 2009. http://d-nb.info/998054445/04.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Sahin, Ebru Karpuzoglu. "Estrogen Regulates Interferon-gamma (IFN-g) and IFN-g-Inducible iNOS Gene Expression: Implications to Immunity and Autoimmunity." Diss., Virginia Tech, 2005. http://hdl.handle.net/10919/27129.

Full text
Abstract:
It is now clear that estrogen not only modulates the differentiation and function of reproductive systems, but it also profoundly regulates the immune system of normal and autoimmune individuals. An important mechanism by which estrogen regulates the immune system is by altering the secretion and/or response to cytokines. We hypothesized that estrogen may alter the levels and/or response to IFN-g, a prototype Th1 cytokine, that plays a pivotal role in immunity against intracellular infections and in many autoimmune and inflammatory disorders. We found that estrogen treatment tended to upregulate the secretion of IFN-g protein and mRNA expression from Concanavalin-A (Con-A)-activated splenic lymphocytes. Impressively, we found that splenocytes from estrogen-treated mice when activated with Con-A also resulted in increased release of nitric oxide compared to placebo-treated mice. Furthermore, Con-A-activated splenocytes from estrogen-treated mice also had upregulated iNOS mRNA, iNOS protein, and nitric oxide-regulated COX-2 protein when compared to control mice. Blocking co-stimulatory signals mediated through interactions of CD28 and B7 molecules by using CTLA-4Ig markedly decreased not only IFN-g, but also nitric oxide, thereby implying an important role for CD28/B7 interactions in IFN-g/nitric oxide. Estrogen-induced upregulation of iNOS/nitric oxide is mediated through IFN-g since: (i) Estrogen alone did not upregulate iNOS/nitric oxide in IFN-g knockout mice; (ii) addition of rIFN-g to activated splenocytes from estrogen-treated mice further upregulated nitric oxide levels. We next investigated whether estrogen also upregulated IFN-g-inducing cytokines and select IFN-g-inducing transcription factors. Estrogen treatment resulted in increased mRNA and/or protein expression of IFN-g inducing cytokines and their receptors, including: IL-18, IL-15, IL-27, IL-12Rb2, and IL-18Rb. We also found that T-bet, a critical Th1 transcription factor, and STAT-4 phosphorylation, a key molecule in IL-12 signaling were both increased, while IRF-4, an important player in Th2 differentiation, was diminished in Con-A-activated splenocytes from mice treated with estrogen. Altogether, these studies are the first to demonstrate that estrogen regulates IFN-g-dependent iNOS and describes the potential mechanisms of how estrogen alters IFN-g-inducible genes, IFN-g inducing cytokines, and transcription factors in normal C57BL/6 mice. These studies may have profound implications to many autoimmune and inflammatory disorders, where estrogen is known to regulate the course of these diseases. Since estrogen may promote inflammatory disorders by upregulating pro-inflammatory biomolecules including IFN-g, nitric oxide, and COX-2, these studies may help in the design of therapeutic agents that regulate or block secretion and/or response to these inflammatory molecules.
Ph. D.
APA, Harvard, Vancouver, ISO, and other styles
17

Schoenborn, Jamie R. "Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing Ifng transcription /." Thesis, Connect to this title online; UW restricted, 2007. http://hdl.handle.net/1773/5098.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Wang, Ling, and Shunbin Ning. ""Toll-Free" Pathways for Production of Type I Interferons." Digital Commons @ East Tennessee State University, 2017. https://dc.etsu.edu/etsu-works/6540.

Full text
Abstract:
Pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) are recognized by different cellular pathogen recognition receptors (PRRs), which are expressed on cell membrane or in the cytoplasm of cells of the innate immune system. Nucleic acids derived from pathogens or from certain cellular conditions represent a large category of PAMPs/DAMPs that trigger production of type I interferons (IFN-I) in addition to pro-inflammatory cytokines, by specifically binding to intracellular Toll-like receptors or cytosolic receptors. These cytosolic receptors, which are not related to TLRs and we call them "Toll-free" receptors, include the RNA-sensing RIG-I like receptors (RLRs), the DNA-sensing HIN200 family, and cGAS, amongst others. Viruses have evolved myriad strategies to evoke both host cellular and viral factors to evade IFN-I-mediated innate immune responses, to facilitate their infection, replication, and establishment of latency. This review outlines these "Toll-free" innate immune pathways and recent updates on their regulation, with focus on cellular and viral factors with enzyme activities.
APA, Harvard, Vancouver, ISO, and other styles
19

McCann, Katelyn J. "IFNγ Mediated Monocyte Metabolic Reprogramming." eScholarship@UMMS, 2021. https://escholarship.umassmed.edu/gsbs_diss/1146.

Full text
Abstract:
IFNγ is an essential and pleiotropic activator of monocytes, but little is known about the effects IFNγ on cellular metabolism. Therefore, we sought to characterize and elucidate the mechanisms by which IFNγ reprograms monocyte metabolism to support its immunologic activities. First, we identified a critical role for IFNγ in the induction of immunoresponsive gene 1 (IRG1) and its product, itaconate. The immunometabolite, itaconate, has been reported to have antibacterial, anti-inflammatory and antioxidant activity. Irg1-/- mice, lacking itaconate, are highly susceptible and phenotypically similar to IFNγ knock out (GKO) mice upon infection with Mycobacterium tuberculosis. Therefore, we assessed the role of IRG1/itaconate in the context of non-tuberculous mycobacterial (NTM) infection, the most common type of infection in patients with immunodeficiencies caused by defects in IFNγ signaling. Our data suggest that impaired induction of itaconate in the context of mycobacterial infection may contribute to mycobacterial susceptibility and immune dysregulation in patients with defects in IFNγ signaling. Next, we evaluated the metabolic phenotype of IFNγ-stimulated human monocytes and found that IFNγ increased oxygen consumption rates (OCR), indicative of reactive oxygen species generation by both mitochondria and NADPH oxidase. Transcriptional profiling of human macrophages revealed that this oxidative phenotype was dependent on IFNγ-induced, nicotinamide phosphoribosyltransferase (NAMPT)-mediated NAD+ salvage to generate NADH and NADPH for oxidation by mitochondrial complex I and NADPH oxidase, respectively. These data identify an IFNγ-induced, NAMPT-dependent, NAD+ salvage pathway that is critical for complete induction of the respiratory burst in IFNγ stimulated human monocytes.
APA, Harvard, Vancouver, ISO, and other styles
20

Gage, Zoe O. "Interferon, viruses and drug discovery." Thesis, University of St Andrews, 2017. http://hdl.handle.net/10023/10127.

Full text
Abstract:
The interferon (IFN) response is a crucial component of cellular innate immunity, vital for controlling virus infections. Dysregulation of the IFN response however can lead to serious medical conditions including autoimmune disorders. Modulators of IFN induction and signalling could be used to treat these diseases and as tools to further understand the IFN response and viral infections. We have developed cell-based assays to identify modulators of IFN induction and signalling, based on A549 cell lines where a GFP gene is under the control of the IFN-β promoter (A549/pr(IFN-β).GFP) and the ISRE containing MxA promoter (A549/pr(ISRE).GFP) respectively. The assays were optimized, miniaturized and validated as suitable for HTS by achieving Z' Factor scores >0.6. A diversity screen of 15,667 compounds using the IFN induction reporter assay identified 2 hit compounds (StA-IFN-1 and StA-IFN-4) that were validated as specifically inhibiting IFNβ induction. Characterisation of these molecules demonstrated that StA-IFN-4 potently acts at, or upstream, of IRF3 phosphorylation. We successfully expanded this HTS platform to target viral interferon antagonists acting upon IFN-signalling. An additional assay was developed where the A549/pr(ISRE).GFP.RBV-P reporter cell line constitutively expresses the Rabies virus phosphoprotein. A compound inhibiting viral protein function will restore GFP expression. The assay was successfully optimized for HTS and used in an in-house screen. We further expanded this assay by placing the expression of RBV-P under the control of an inducible promoter. This demonstrates a convenient approach for assay development and potentiates the targeting of a variety of viral IFN antagonists for the identification of compounds with the potential to develop a novel class of antiviral drugs.
APA, Harvard, Vancouver, ISO, and other styles
21

Santillo, Bruna Tereso. "Caracterização fenotípica e funcional de IFN-DCs derivadas de indivíduos infectados pelo HIV-1." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/42/42133/tde-09122015-130521/.

Full text
Abstract:
A imunoterapia baseada em MoDC constitui uma estratégia para tratamento de indivíduos HIV+. Protocolos para obtenção de MoDC em geral utilizam IL-4 e GM-CSF (IL4-DC). Alguns estudos utilizam as IFN-DC (IFN-α + GM-CSF), que exibem um fenótipo combinado de DC mielóide, DC plasmocitóide (pDC) e célula NK. Esse perfil misto pode aperfeiçoar a imunoterapia para pacientes HIV+. Para tanto, monócitos de pacientes HIV+ foram cultivados com GM-CSF e IL-4 ou IFN-α por 5 dias e estimuladas por 48 horas com pulso de HIV inativado por AT-2 e/ou coquetel de citocinas pró-inflamatórias. Avaliamos a expressão de moléculas de superfície de IFN-DC e ativação de linfócitos T por citometria de fluxo; produção de citocinas IL-12 e IL-10 por ELISA. IFN-DC apresentaram morfologia e fenótipo basais ativados e características de pDC e célula NK, diferente das IL4-DC. As IFN-DC foram capazes de produzir IL-12, estimular a proliferação e produção de IFN-γ de linfócitos TCD4 e CD8, porém similares às IL4-DCs. IFN-DC são capazes de estimular resposta de linfócitos T tanto quanto IL4-DC.
Immunotherapy based on MDDCs is a strategy for treating HIV-infected patients. Alternatively to the conventional protocol for DC differentiation based on IL-4 and GM-CSF (IL4-DC) some studies suggest the use of IFN-DC (IFN-α + GM-CSF). These cells exhibit a combined phenotype of myeloid DC, plasmacytoid DC (pDC) and NK. Considering the mixed profile of IFN-DCs alternative protocols can bring novel elements for immunotherapy. Monocytes isolated from HIV-infected patients were cultured in the presence of GM-CSF and IL-4 or IFN-α. On day 5 DCs were pulsed with AT-2-inactivated HIV and stimulated for 48 hours with a cocktail of proinflammatory cytokines. We assessed IFN-DC surface markers expression and T cell activation by flow cytometry; IL-10 and IL-12 production by ELISA. IFN-DC showed activated morphological and phenotypic features during basal state of maturity and exhibited features of pDC and NK different from IL4-DC. The IFN-DC like IL4-DC were able to produce IL-12 and stimulated T cells. So, the IFN-DC were able to stimulate the T cells as well as IL4-DCs.
APA, Harvard, Vancouver, ISO, and other styles
22

Stewart, Claire Emma. "Viruses and the interferon (IFN) response : methods to improve production and to rapidly select IFN-sensitive viruses for vaccine development." Thesis, University of St Andrews, 2017. http://hdl.handle.net/10023/11346.

Full text
Abstract:
Manipulation of a virus's capacity to circumvent the interferon (IFN) response aids both fundamental studies as well as many practical applications including the design of live-attenuated vaccines. However, these IFN-sensitive viruses are often difficult to grow to high titer in cells that produce and respond to IFN. In the first part of this study we further characterised the use of the IFN inhibitor, Ruxolitinib (Rux) for its ability to block the IFN response and subsequently enhance replication of IFN-sensitive viruses. This study has shown that i) Rux could provide a more rapid and therefore more efficient alternative for the growth of IFN-sensitive viruses than the current default option, growth in Vero cells and ii) addition of Rux can increase growth of multiple viruses in numerous cell-lines. These results indicate that as well as aiding fundamental studies the addition of Rux could become a valuable technique in a number of virological applications including live attenuated vaccine production and techniques to isolate newly emerging viruses. In the second part of this study we developed a novel method to isolate IFN-sensitive viruses from Paramyxoviruses, using PIV5 (Parainfluenza virus 5) as an experimental model system to obtain selection parameters. We successfully isolated three mutant viruses (rPIV5mCh-α, rPIV5mCh-β and PIV5 W3-γ) that each contain mutations within the IFN antagonist V protein and the P protein which is essential for RNA replication. Subsequently, both rPIV5mCh-α and PIV5 W3-γ were shown to contain non- functional V proteins and exhibit IFN-sensitivity. Ultimately, this study is the first step towards creating a general method to isolate various types of IFN-sensitive viruses that as well as aiding fundamental studies, may be further developed as attenuated vaccines for clinically important viruses lacking vaccines.
APA, Harvard, Vancouver, ISO, and other styles
23

Santos, Tatiane Assone dos. "Associação dos polimorfismos de IFN-lambda 4, KIR e HLA-C em pacientes vivendo com HTLV-1." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/99/99131/tde-24012017-082140/.

Full text
Abstract:
As doenças virais têm sido importantes causas de morbidade e mortalidade nas últimas décadas, sendo que algumas delas são relacionadas com polimorfismos genéticos, que determinam a susceptibilidade do hospedeiro ou a resistência a essas infecções, influenciando na patogênese, além de desempenhar importante papel em respostas ao tratamento. Entre elas, destaca-se o HTLV-1, sendo que cerca de 10 a 20 milhões de pessoas em todo o mundo possuem esse vírus. Apenas 5% dos indivíduos infectados desenvolverão algum tipo de doença relacionada a tal infecção, entre elas destaca-se a HAM/TSP. Apesar da complexidade, o entendimento das interações hospedeiro versus HTLV-1 é de fundamental importância para avaliar prognóstico clínico dos portadores assintomáticos, visto que as opções diagnósticas e de tratamento não são adequadas, até o momento, para determinar o risco de progressão para HAM/TSP. Com isso, este trabalho objetivou estudar a associação entre alguns marcadores virais, genéticos e imunológicos relacionados ao desenvolvimento de HAM/TSPem pacientes infectados por HTLV-1. O ambulatório de HTLV do Instituto de Infectologia \"Emilio Ribas\" (IIER) possui uma coorte de portadores de HTLV em seguimento há 19 anos, para o presente estudo foram selecionados 247 voluntários portadores de HTLV-1, por conveniência. Somente pacientes adultos, com seguimento ativo no ambulatório no período de junho de 2011 até julho de 2016 foram convidados a participar. Este protocolo foi aprovado pelo CEP do IIER (Nº13/2011), e o TCLE foi obtido de todos os voluntários participantes. Os indivíduos foram classificados de acordo com seu quadro clínico neurológico em dois grupos: Grupo I (160 assintomáticos) e Grupo II (87 HAM/TSP). Amostra de sangue venoso foi coletada e as células mononucleares separadas. O material foi utilizado para o ensaio de PVL e para a genotipagem de IFN-?4, HLA-C e KIR, pela técnica de qPCR . A análise estatística no modelo multivariado mostrou associação de risco para HAM/TSP com as variáveis LPA (p=0,001) e a idade (p=0,019), além disso, o polimorfismo doIFN-?4 no rs8099917 foi associado no modelo recessivo(OR=0,31, IC=0,105 - 0,961) como fator de proteção ao desfecho.:Esse modelo estudado explica 8% dos fatores de progressão e de proteção para HAM/TSP. Desse modo, estudos genéticos multicêntricos envolvendo análise de exoma e maior número de casos de HAM/TSP, deveriam ser realizados. O entendimento da patogênese da mielopatia pode oferecer marcadores de valor prognóstico importantes para o manejo clínico, além de contribuir para o achado de novas intervenções terapêuticas no futuro.
The viral diseases have been major causes of morbidity and mortality in recent decades, some of which are related to genetic polymorphisms, which determine the susceptibility or resistance to these infections, influencing the pathogenesis, besides of playing an important role in responses to treatment. Among them, it is highlighted HTLV-1, in which around 10 to 20 million people worldwide. Only 5% of infected subjects will develop some kind of disease related to such infection, including HAM/TSP. Despite the complexity, the understanding of host interactions versus HTLV-1 is fundamental importance to evaluate clinical prognosis of asymptomatic subjects, once the diagnostic options and treatment are not adequate, so far, to determine the risk of progression to HAM/TSP. Therefore, the purpose of this study was to investigate the association among some genetic polymorphisms, viral and immunological markers related to the development of HAM/TSP in HTLV-1-infected subjects. At the Institute of Infectious Diseases \"Emilio Ribas\" (IIER) has a cohort of HTLV subjects followed up for 19 years, for this study 247 volunteers with HTLV-1were selected for convenience. Only adult patients with active follow up in the period from June 2011 to July 2016 were invited to participate. This protocol was approved by the ethical committee at IIER (nº13/2011), informed consent was obtained. Subjects were classified according to their neurological status in two groups: Group I (160 asymptomatic) and Group II (87 HAM / TSP). Blood sample was collected and PBMCs The DNA was used to the PVL assay and IFN-?4, HLA-C and KIR genotyping using qPCR. It has been observed an association to HAM/TSP with LPA variables (p=0.001) and age (p=0.019) in the multivariable analysis. On the other hand, the polymorphism of IFN-?4 rs8099917 was associated in the recessive model (OR=0.31, CI=0.105-0.961) as a protective factor to HAM/TSP. This study explains 8% of progression and protective factors for HAM/TSP. Thus, multi-center studies involving genetic analysis and more cases of HAM/TSP, should be done. The understanding of the HAM/TSP pathogenesis can provide important markers of prognostic value for clinical management and contribute to the discovery of new therapeutic interventions in the future.
APA, Harvard, Vancouver, ISO, and other styles
24

Bucci, Daniella Zanetti. "Ação do IFN-g sobre as células não leucocitárias (células estruturais) na infecção pelos protozoários Trypanosoma cruzi e Plasmodium." Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/42/42133/tde-06012015-140117/.

Full text
Abstract:
O objetivo central desta dissertação de mestrado foi analisar se, pela sua resposta ao interferon-g (IFNg), as células não leucocitárias contribuem ao controle dos protozoários Trypanosoma cruzi, Plasmodium chabaudi AS e Plasmodium berghei ANKA. O IFNg é uma citocina que promove a ativação de diversos tipos de leucócitos, a sua ação sobre as células mononucleares fagóciticas merece um destaque especial. Apesar de conhecermos os pormenores do papel desta citocina na ativação dos leucócitos, desconhecemos se o IFNg exerce ação ativadora sobre as células estruturais (não leucocitárias), ou seja, sobre as células não profissionais da resposta imune. A nossa hipótese de trabalho é que, no caso dos parasitas intracelulares, o IFNg poderia reforçar a ação sinalizadora e efetora das células estruturais infectadas. Por outro lado, em ambas as situações de parasitas intracelulares e extracelulares, o IFNg, ao agir sobre diversas células estruturais, poderia induzir a produção de mediadores inflamatórios (citocinas, quimiocinas, etc) que contribuiriam direta ou indiretamente à remoção/controle do parasita. A nossa abordagem tem sido o estudo da infecção por estes protozoários em quimeras de medula óssea B6/IFNgRKO, nas quais as células não leucocitárias são deficientes em receptores para IFNg e as células leucocitárias são normais. A análise por imunofluorescência de cortes histológicos mostrou uma alta expressão de IFNgR pelas células estruturais do coração dos animais B6 e quimeras controle B6/B6, mas nenhuma expressão deste receptor nos cortes histológicos correspondentes de animais IFNgRKO e quimeras experimentais B6/IFNgRKO, apesar de grande parte dos leucócitos dos animais deste último grupo ter se tornado IFNgR+. Após infecção pelo T. cruzi, o coração e músculo esquelético dos animais quiméricos B6/IFNgRKO mostraram maior carga parasitária e menor intensidade dos infiltrados 8 inflamatórios do que aqueles dos animais quiméricos B6/B6, resultados que sugerem o envolvimento das células estruturais no controle do parasita e promoção do recrutamento leucocitário. Na infecção pelo Plasmodium chabaudi AS a análise comparativa dos grupos IFNgRKO e quimera B6/IFNgRKO mostrou que no início da infecção as curvas de parasitemia destes grupos são idênticas sugerindo que nesta fase da infecção a presença do IFNgR nos leucócitos em pouco contribui na evolução da parasitemia. Por outro lado, a análise comparativa dos grupos quimera B6/IFNgRKO e quimera B6/B6 mostrou níveis mais elevados de parasitemia e maior índice de mortalidade nos animais B6/IFNgRKO, sugerindo que as células estruturais participam no controle do parasita através da sua resposta ao IFNg. Entretanto, em uma experiência preliminar de infecção pelo Plasmodium berghei ANKA não observamos grandes diferenças entre os animais dos grupos B6/IFNgRKO e B6/B6, não somente no que se refere à curva de parasitemias, como também na indução de morte precoce decorrente de malária cerebral.
The main purpose of our work was to analyze if by their response to Interferon-g (IFN-g), the non-leucocyte cells are able to control Trypanosoma cruzi, Plasmodium chabaudi AS and Plasmodium berghei ANKA protozoans. IFNg was described as a cytokine that promote activation on different types of leucocytes, its action on mononuclear phagocytic cells is important. Despite the fact that this cytokine activate leucocytes, it is unknown whether IFNg activates the structural cells (non-leucocytes), that is, the non-professional cells of the immune response. Our hypotheses suggest that in the case of intracellular parasites, IFNg could help the infected structural cells by increasing their signaling and effect actions. In addition, during the response against intracellular and extracellular parasites, IFNg could induce the production of inflammatory mediators by these cells guaranteeing direct or indirectly the parasite clearance. In the present study, we analyzed the infection of diferente protozoans on bone marrow B6/IFNgRKO chimeras, in which the non-leukocyte cells are deficient in IFNg receptor and the leukocyte cells are normal. Immunofluorescence analyses of histological sections revealed a high expression of IFNgR on the structural cells from the heart of B6 and control chimeras B6/B6 animals, but non-expression of this receptor on histological sections from IFNgRKO and experimental chimeras B6/IFNgRKO, despite the fact that a great part of leucocytes from the last group of animals express the receptor. After T. cruzi infection, the cardiac and skeletal muscle from B6/IFNgRKO chimera animals showed a huge amount of parasite and less infiltration inflammatory than B6/B6 animals, suggesting that the structural cells are involved in the parasite control and leukocyte recruitment. During Plasmodium chabaudi AS infection, comparative analyses from IFNgRKO and 10 B6/IFNgRKO groups showed that parasitemia curves at the early phase are similar, suggesting that during this phase IFNgR expression on leukocytes are not important. On the other hand, parasitemia and mortality levels on B6/IFNgRKO and B6/B6 groups were higher than those on B6/IFNgRKO animals, determining that structural cells participate during the course of infection through their response to IFNg. However, when B6/IFNgRKO and B6/B6 animals were infected with Plasmodium berghei ANKA no significantly difference was observed between these groups related to the course of parasitemia and cerebral malaria.
APA, Harvard, Vancouver, ISO, and other styles
25

Pina, Lígia Isabel Gomes de. "Esclerose múltipla: terapêutica com IFN-β." Master's thesis, [s.n.], 2012. http://hdl.handle.net/10284/3202.

Full text
Abstract:
Trabalho apresentado à Universidade Fernando Pessoa, como parte dos requisitos para obtenção do grau de Mestre em Ciências Farmacêuticas
A esclerose múltipla (EM) é a doença crónica mais comum do sistema nervoso central (SNC) e é caracterizada pela destruição da mielina. Hoje em dia é objecto de inúmeras pesquisas para determinar com precisão as suas causas e definir um tratamento eficaz. A diferente susceptibilidade à doença entre homens e mulheres, negros e caucasianos, jovens e idosos e a distribuição geográfica díspar da EM parece sugerir uma interacção efectiva entre factores genéticos e ambientais. Apesar de ser uma doença auto-imune, o tratamento com imunossupressores ficou aquém das expectativas e começaram a utilizar-se imunomoduladores como o Interferão beta (IFN-β) de modo a reduzir a frequência e a gravidade dos surtos. Multiple sclerosis is the most common chronic disease of the central nervous system and is characterized by the destruction of myelin. Nowadays is subject of numerous studies to establish accurately the causes and define an effective treatment. The different susceptibility to disease between men and women, blacks and whites, young and old and unequal geographical distribution of MS appears to suggest an effective interaction between genetic and environmental factors. Although it is an autoimmune disease, treatment with immunosuppressive agents is still poor and it was initiated the use of immunomodulators such as interferon beta (IFN-β) to reduce the frequency and severity of the attacks.
APA, Harvard, Vancouver, ISO, and other styles
26

Koch, Oliver. "Common genetic variants of the IFN-γ and IFNGR1 regions : disease associations and functional properties." Thesis, University of Oxford, 2003. http://ora.ox.ac.uk/objects/uuid:30fc15ae-13e5-4150-8093-2582334e75c0.

Full text
Abstract:
There is growing evidence that susceptibility to many inflammatory and infectious diseases may be influenced by our genetic make up. Genetic variants in important immune genes may partially explain variation in susceptibility to common diseases. Interferon-γ (IFNγ) is one of the central mediators of the innate and adaptive immunity and has been implicated in a wide range of infectious and inflammatory disease processes. Severe disruptive mutations in coding regions of the IFN-γ receptor 1 gene (IFNGR1) have been found to be associated with fatal but very rare mycobacterial infections. This study looked at common polymorphisms in potentially regulatory non-coding regions of the IFNγ gene and the IFNGR1 gene and investigated their association with susceptibility to severe malaria, a disease for which there have been indications of a genetic component to susceptibility. Malaria is one of the major causes of childhood deaths in Africa. IFNγ and its receptor have been shown to be critically involved in the host response to the malaria parasites. The promoter regions of IFNGR1 and its neighbouring genes, located on chromosome 6q23, and IFNγ and its neighbours, on chromosome 12ql4, were screened for polymorphisms. Haplotypes and linkage disequilibrium maps were constructed, signatures of natural selection were investigated, haplotype tagging SNPs were dentified, and association with disease was analysed. One of these preliminary results was a putative association between the IFNGRl-470ddel allele and susceptibility to severe malaria in the Mandinka ethnic group. This allele was in strong linkage disequilibrium (LD) with markers which are a considerable distance away which might represent a signature of natural selection. To assess the potential functional significance of the IFNGR1-47Q polymorphism, its effects on DNA-protein interactions and gene expression was investigated further in various cell lines. Evidence of tissue-specific nuclear protein binding to this site which seems to be involved in transcriptional regulation was observed.
APA, Harvard, Vancouver, ISO, and other styles
27

Amalraj, James. "Gene Regulation Associated with IFN-Resistance Mechanisms in Melanoma." Thesis, Griffith University, 2012. http://hdl.handle.net/10072/366926.

Full text
Abstract:
Melanoma is the most aggressive form of skin cancer with rapidly increasing rates of incidence in fair-skinned populations worldwide. The most promising current treatment for advanced stage melanoma involves a combination of chemotherapy and interferon alpha (IFN-α), although complete response rates are unacceptably low. Loss of sensitivity to IFNs in melanoma cells has been shown to arise from a deficiency in the level of intracellular signalling molecules including STAT1, STAT2 & IRF9, which are important transcription factors in the IFN signalling pathway. Of these, deficiencies in STAT1 show the greatest correlation with IFN resistance. Greater understanding of the regulation of STAT1 gene transcription is important for predicting, and potentially improving, IFN mediated activity in malignant melanomas. In a previous study, distinct enhancer and repressor regions were shown to be present in the first and second introns of the human STAT1 gene. A gene segment comprising 123 base pairs located in the second intron was shown to confer specific repression of reporter gene constructs in melanoma cell lines. Within this regulatory region, we have identified a putative repressor element-1 (RE1) site, and shown binding of the RE1 silencer of transcription (REST) protein in melanoma cell lines by chromatin immunoprecipitation (ChIP) assays. In transient transfection assays, a luciferase gene reporter construct comprising the RE1 sequence from the STAT1 gene cloned immediately downstream of the STAT1 promoter and enhancer regions exhibited significant repression of reporter gene activity. Furthermore, progressively stronger repression was conferred by cloning tandem copies of the STAT1-RE1 sequence adjacent to the promoter/enhancer region, confirming the repressive activity of this element. The partial loss of repression of the STAT1 promoter by the RE1 element in a cell line expressing a low level of the REST protein further confirmed the functional significance of REST and the RE1 element within the STAT1 gene.
Thesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medical Science
Griffith Health
Full Text
APA, Harvard, Vancouver, ISO, and other styles
28

Kotla, Swathi, and Kurt E. Gustin. "Proteolysis of MDA5 and IPS-1 is not required for inhibition of the type I IFN response by poliovirus." BioMed Central, 2015. http://hdl.handle.net/10150/610336.

Full text
Abstract:
BACKGROUND: The type I interferon (IFN) response is a critical component of the innate immune response to infection by RNA viruses and is initiated via recognition of viral nucleic acids by RIG-like receptors (RLR). Engagement of these receptors in the cytoplasm initiates a signal transduction pathway leading to activation of the transcription factors NF-κB, ATF-2 and IRF-3 that coordinately upregulate transcription of type I IFN genes, such as that encoding IFN-β. In this study the impact of poliovirus infection on the type I interferon response has been examined. METHODS: The type I IFN response was assessed by measuring IFN-β mRNA levels using qRT-PCR and normalizing to levels of β-actin mRNA. The status of host factors involved in activation of the type I IFN response was examined by immunoblot, immunofluorescence microcopy and qRT-PCR. RESULTS: The results show that poliovirus infection results in induction of very low levels of IFN-β mRNA despite clear activation of NF-κB and ATF-2. In contrast, analysis of IRF-3 revealed no transcriptional induction of an IRF-3-responsive promoter or homodimerization of IRF-3 indicating it is not activated in poliovirus-infected cells. Exposure of poliovirus-infected cells to poly(I:C) results in lower levels of IFN-β mRNA synthesis and IRF-3 activation compared to mock-infected cells. Analysis of MDA-5 and IPS-1 revealed that these components of the RLR pathway were largely intact at times when the type I IFN response was suppressed. CONCLUSIONS: Collectively, these results demonstrate that poliovirus infection actively suppresses the host type I interferon response by blocking activation of IRF-3 and suggests that this is not mediated by cleavage of MDA-5 or IPS-1.
APA, Harvard, Vancouver, ISO, and other styles
29

Santos, Michelle Carolina dos [UNIFESP]. "Avaliação das populações de linfócitos produtores de IFN-g e IL-17 em pacientes sépticos e relação com o desfecho clínico." Universidade Federal de São Paulo (UNIFESP), 2010. http://repositorio.unifesp.br/handle/11600/9057.

Full text
Abstract:
Made available in DSpace on 2015-07-22T20:49:33Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-07-28
A resposta inflamatória é modulada durante a sepse e a regulação positiva ou negativa da atividade celular depende das células e funções avaliadas. IFN-γ e IL-17 são citocinas características das subpopulações de linfócitos Th1 e Th17, respectivamente, e desempenham papel importante na resposta imune, ligando a imunidade inata e adaptativa. Objetivo: Avaliar a presença das células Th1 e Th17 em pacientes sépticos na admissão do estudo (D0) comparado-a com sadios e após 7 dias (D7) de seguimento. Casuística e Métodos: Foram incluídos 59 pacientes sépticos no D0, dos quais 31 tiveram amostras colhidas no D7, e 30 indivíduos sadios. As células mononucleares do sangue periférico foram separadas e congeladas em nitrogênio líquido. Após descongelamento e ajuste da concentração para 1x106 células/mL, as células foram estimuladas ou não com PMA/ionomicina e mantidas por 30 minutos em estufa a 37ºC a 5% CO2. Foi acrescentado brefeldina A e incubadas por mais 15 horas. Em seguida, foi feita marcação de superfície para a identificação dos linfócitos TCD4 (CD3+CD8-). As células foram permeabilizadas e marcadas para detecção de IL-17A e IFN-γ intracelular. As amostras foram lidas em citômetro FACSCanto e analisadas no programa FlowJo. Resultados: A produção basal de IFN-γ e IL-17A foi maior nos pacientes comparado aos sadios (P=0,002 e P<0,001, respectivamente). Após estímulo, a produção de IL-17A foi maior nos pacientes (P=0,027) enquanto a de IFN-γ foi superior nos sadios (P=0,001). Ao comparar os diferentes estadios da sepse, foi observado aumento na produção de IFN-γ após estímulo com PMA/ionomicina nos pacientes em choque séptico em relação aos pacientes em sepse grave (P=0,039). A produção de IFN-γ basal e após estímulo mostrou-se aumentada no D7 em relação ao D0 (P=0,007 e P=0,018, respectivamente). Em contraste, a produção de IL-17 após estímulo foi maior no D0 comparado ao D7 (P=0,003), mas não foi encontrada diferença significativa na condição basal. Nos pacientes que evoluíram a óbito, as amostras do D0 apresentaram menor produção constitutiva de IFN-γ em relação ao D7 (P=0,023), mas após estímulo não foi encontrada diferença. Nos pacientes que sobreviveram, não houve diferença na condição basal e após estímulo com PMA/ionomicina. A produção de IL-17, após estímulo foi maior na amostra D0 em relação ao D7 (P=0,006) nos pacientes que sobreviveram, já na condição basal não houve diferença. Os pacientes que evoluíram a óbito não apresentaram diferença na condição basal e após estímulo com PMA/ionomicina. Conclusão: Os resultados basais com maior produção de citocinas nos sépticos refletem o grau de inflamação característico da sepse. Observamos uma dicotomia entre as respostas Th1 e Th17 após PMA/ionomicina nos pacientes sépticos, com aumento da população Th17 e diminuição da Th1 em relação aos sadios. Aumento da população Th1 no D7 foi relacionado com mortalidade, enquanto diminuição da população Th17 foi relacionada com sobrevida, indicando que a persistência ou exacerbação das respostas Th1 e Th17 podem ser deletérias. Estes achados sugerem regulação da resposta inflamatória na sepse das populações Th1 e Th17.
The inflammatory response is modulated during sepsis and up or down regulation of cell activity depends on cells and functions evaluated. IFN-g and IL-17 are cytokines characteristics of lymphocyte subsets Th1 and Th17, respectively, and play an important role in immune response, linking innate and adaptative immunity. Objective: To evaluate the presence of Th1 and Th17 cells in septic patients at admission of the study (D0) compared it with healthy volunteers and after 7 days (D7) follow-up. Material and Methods: We included 59 septic patients on D0, of which 31 had samples collected on D7, and 30 healthy individuals. The peripheral blood mononuclear cells were separated and frozen in liquid nitrogen. After thawing and adjust the concentration to 1x106 cells/mL, cells were stimulated or not with PMA/ionomycin for 30 minutes and maintained at 37oC 5% CO2. Brefeldin A was added and cells were incubated for another 15 hours. Then cells were surface stained for identification of TCD4 lymphocytes (CD3+CD8-). Cells were permeabilized and stained for detection of IL-17A and IFN-g intracellular. The samples were read in FACSCanto cytometer and analyzed with FlowJo program. Results: The basal production of IFN-g and IL-17A was higher in patients compared to healthy volunteers (P=0,002 e P<0,001, respectively). After stimulation, the production of IL-17A was higher in patients (P=0,027) while the IFN-g was higher in healthy (P=0,001). An increase IFN-g production after stimulation with PMA/ionomycin was found in patients with septic shock compared to severe sepsis (P=0,039). The baseline production of IFN-g and after PMA/Ionomycin stimulation was found to be increased in D7 in relation to D0 (P=0,007 e P=0,018, respectively). In contrast, the production of IL-17 after stimulation was higher in D0 compared to D7 (P=0,003). In patients who died, the D0 samples showed lower constitutive IFN-g production compared to D7 (P=0,023), but after a stimulus, no difference was found. In patients who survived, there was no difference at baseline and after stimulation with PMA/ionomycin. The IL-17 production, after stimulation, was higher in D0 sample compared to D7 (P=0,006) in patients who survived. No difference between D0 and D7 was found in patients who survived. Conclusion: The results with higher basal detection of IFN-g and IL-17 producing cells in septic patients reflect the degree of inflammation characteristic of sepsis. A dichotomy between Th1 and Th17 responses after PMA/ionomycin stimulation was found in septic patients, with increased Th17 population and decreased Th1 compared to healthy individuals. A higher proportion of Th1 in D7 was observed in patients who died; while a decrease of Th17 population was observed in patients who survived, indicating that the persistence or higher Th1 and Th17 responses may be deleterious. These findings suggest regulation of the inflammatory response in sepsis of Th1 and Th17 populations.
TEDE
BV UNIFESP: Teses e dissertações
APA, Harvard, Vancouver, ISO, and other styles
30

Eboumbou, Moukoko Else Carole. "Evaluation des effets de polymorphismes génétiques (TNF-alpha, IFN-gamma, IFN-gamma R1) et de coinfections virales (VHB, VHC) sur la fibrose de symmers." Paris 6, 2003. http://www.theses.fr/2003PA066106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Ferreira, Márcio José. "Expressão de IFN-gama e interleucina (IL)-10 e seus receptores pelas células trofoblásticas de camundongos." Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/42/42134/tde-03062008-110226/.

Full text
Abstract:
Analisamos a expressão de IL-10, IFN-g e, seus receptores pelas células trofoblásticas de camundongos, citocinas anti e pró-inflamatórias. Cones ectoplacentários aos 7,5 dias de gestação foram cultivados por 48 h e em seguida tratados com 100 U/mL IFN-g ou 10 hg/mL IL-10. Após 6 h e 14 h, as amostras foram processadas para análise da expressão gênica por RT-PCR e protéica por imunohistoquímica, respectivamente. Grupos controle não receberam tratamento. IFN-g aumentou a expressão de IL-10R1 mas não a de IL-10 nas células trofoblásticas. IL-10, ao contrário, aumentou a expressão de IFN-g, mas diminuiu IFN-gRa e não alterou IFN-gRb. Reações imunohistoquímicas confirmaram os resultados de expressão gênica. Isto sugere que o trofoblasto pode participar da imunidade da interface materno-placentária aumentando a expressão de IFN-g em situações em que no meio há aumento de citocinas anti-inflamatórias, o que deve ser o reflexo da necessidade e importância desta citocina para o sucesso da gestação.
Key cytokines such as IL-10 and IFN-g, essential for immune response regulation, have also been found locally at maternal-placental interface during mouse pregnancy. Particularly, levels of IL-10 characterize an anti-inflammatory environment associated to the inhibition of T helper-1 lymphocytes (Th1) development and the proliferative stimulation of the B lymphocytes (humoral response). On the other hand, increases in IFN-g profile prevent T helper-2 lymphocytes (Th2) activation leading to an inflammatory response that favors a Th1 response. The local production of these cytokines by NK uterine cells and T gd lymphocytes are relevant, but not exclusive. Thus, this study analyzed the potential contribution of the trophoblast in the maintenance of Th1/Th2 balance in the maternal-placental interface, represented, respectively by the expression of IL-10 and IFN-g cytokines. The expression of the anti-inflammatory cytokine IL-10 and its receptor was evaluated in the presence of an inflammatory environment mimetized by IFN-g addition to the culture medium. On contrary, the expression of the IFN-g (and its receptor) was evaluated in the presence of IL-10 characterizing an anti-inflammatory condition. Mouse trophoblast cells were isolated from implantation sites at gestational day 7.5 and cultured in standard conditions. Gene and protein expression were determined by immunohistochemistry and RT-PCR. IL-10 and IFN-g and their receptors were expressed in cultured trophoblast cells in the absence or presence of IFN-g and IL-10, respectively. IFN-g treatment increased IL-10R1 expression but do not alter IL-10 expression. On contrary, in the presence of IL-10 the IFN-g expression increased significantly while the expression of its receptor decreased. These results suggest that a proinflammatory environment increases trophoblast responsiveness to IL-10 whereas an anti-inflammatory condition seems to reinforce the importance of IFN-g expression at the maternal-placental interface, on the initial periods of gestation.
APA, Harvard, Vancouver, ISO, and other styles
32

Alshehri, Abdullateef Abdullah Salem. "Defining the Mechanism of ISGs Induction and Type I Interferon Inhibition in HIV-1 Infected Mononuclear Phagocytes." Thesis, The University of Sydney, 2017. http://hdl.handle.net/2123/18192.

Full text
Abstract:
Dendritic cells (DC) and macrophages are mononuclear phagocytes present in the tissues of the anogenital tract where HIV-1 transmission occurs in almost all cases. These cells are both target cells for HIV-1 and act as the primary opportunity for the virus to inhibit the innate recognition. Our lab has previously shown that both cell types fail to produce type I interferons (IFN) in response to HIV-1. However, it stimulates them to produce specific subsets of interferonstimulated genes (ISGs) some of which have direct antiviral activity. Our lab defined the precise stage in the IFN inducing signalling pathway that HIV-1 targets; blocking the phosphorylation but not K63 polyubiquitination of TANK-binding kinase 1 (TBK1). Finally, we showed that this is mediated by two HIV-1 accessory proteins, Vpr and Vif. In the first results chapter (3) of this thesis, we show that ISG expression is governed by two phases: an initial induction through the detection of the incoming HIV-1 inoculum at 1-6 hpi and then a second phase predominantly by newly transcribed HIV-1 as observed after 72 hpi. We also show that knockdown of either Tat, IRF1 or IRF7 ablated the second phase of ISG subset and that Tat/IRF7 induction of the second phase ISGs is down stream of IRF1. In the second results chapter (4), we demonstrate that Vpr (but not Vif, Nef or Vpu) is the only accessory protein observed to co-immunoprecipitate with TBK1 in the absence of other viral proteins. This was shown using two different Co-IP assay methods (G-Sepharose beads and the Trap system). Therefore, this supports our hypothesis that HIV-1 inhibits IFN signalling in mononuclear phagocytes by physical interactor of its protein with TBK1, thereby blocking its functional role in IFN signalling. Defining the minimal binding regions TBK1 and Vpr interaction could allow the development of small molecule inhibitors of the interaction that would rescue IFNβ production in these cells and reduce HIV replication and spread.
APA, Harvard, Vancouver, ISO, and other styles
33

Castro, Analia Zuleika de. "Imunidade celular de pacientes portadores de Tuberculose pulmonar. Participação do fator transformador de crescimento beta (TGF-beta) e interferon gama (IFN-gama)." [s.n.], 1997. http://repositorio.unicamp.br/jspui/handle/REPOSIP/316936.

Full text
Abstract:
Orientadores: Leonilda Maria Barbosa Santos, Ilma Aparecida Paschoal
Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-07-22T08:08:39Z (GMT). No. of bitstreams: 1 Castro_AnaliaZuleikade_M.pdf: 5313468 bytes, checksum: 7ab49045ee18e55595dcf9f1515981c3 (MD5) Previous issue date: 1997
Mestrado
Imunologia
Mestre em Ciências Biológicas
APA, Harvard, Vancouver, ISO, and other styles
34

Jesus, Luciano Augusto Oliveira de. "ProduÃÃo de ifn-y em pacientes com hansenÃase e em seus contactantes numa amostra populacional do MunicÃpio de Sobral - CearÃ." Universidade Federal do CearÃ, 2007. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=1242.

Full text
Abstract:
Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃgico
A hansenÃase, cujo agente etiolÃgico à o Mycobacterium leprae, à doenÃa de amplo espectro clÃnico e imunopatolÃgico. Suas apresentaÃÃes clÃnicas estÃo correlacionadas com padrÃes imunolÃgicos distintos, variando de uma vigorosa resposta imune mediada por cÃlulas ao M. leprae, com padrÃo tipo 1 no polo tuberculÃide, a uma ausÃncia de resposta celular especÃfica aos antÃgenos do M. leprae no pÃlo lepromatoso, com predomÃnio de resposta tipo 2 e exacerbaÃÃo da resposta humoral. A capacidade do antÃgeno bruto de M. leprae em estimular cÃlulas mononucleares do sangue perifÃrico (PBMC) na produÃÃo de IFN-y foi avaliada em pacientes com hansenÃase e em seus contactantes, do municÃpio de Sobral-CE. Um total de 30 casos foi estudado, antes de receberem tratamento poliquimiterÃpico. O grupo de casos paucibacilares foi constituÃdo por oito com a forma indeterminada, dez com a forma tuberculÃide, dois com a forma dimorfo tuberculÃide; e o grupo multibacilar foi constituÃdo por dez com a forma virchoviana e dois com a forma dimorfa virchoviana. O grupo de contactantes foi constituÃdo por sessenta indivÃduos, sendo 1 consangÃÃneo e 1 nÃo consangÃÃneo para cada caso Ãndice. O antÃgeno bruto de M. leprae estimulou a produÃÃo de IFN-y nas PBMC de sete casos dimorfo tuberculÃide/tuberculÃide (DT/TT), trÃs com a forma indeterminada e dois com a forma dimorfa virchoviana/virchoviana (DV/VV). O grupo DT/TT produziu nÃveis de IFN-y significantemente maiores que o grupo DV/VV (Teste de Fisher, p=0,027). A produÃÃo de IFN-y nos contactantes foi observada em 34 indivÃduos, 21 consangÃÃneos e 13 nÃo consangÃÃneos. NÃo foi observada diferenÃa significativa entre os contactantes do grupo paucibacilar (forma indeterminada, DT/TT) e multibacilares (DV/VV). PorÃm, foi observada diferenÃa significativa na produÃÃo desta citocina entre contactantes e casos DV/VV. O estudo sugere que nÃo hà diferenÃa significativa na produÃÃo de IFN-y entre indivÃduos contactantes consangÃÃneos e nÃo consangÃÃneos, dos casos paucibacilares e multibacilares. AlÃm disso, ao correlacionarmos a produÃÃo desta citocina nos indivÃduos com a presenÃa de cicatriz, tambÃm nÃo observamos diferenÃa significativa
Leprosy, which is caused by Mycobacterium leprae, is an illness of ample clinical and immunopathological spectrum. Its clinical manifestations are correlated with distinct immunologic form, varying from a vigorous immune response mediated by cells to M. leprae, with type 1 standard in the tuberculÃide polar region, to an absence of specific cellular response to antigens of M. leprae in the lepromatous polar region, with predominance of type 2 response and exacerbations of humoral response. The capacity of whole M. leprae antigen to stimulate peripheral blood mononuclear cell (PBMC) in the IFN-y production was measured in leprosy patients and their householdâs contacts, in the city of Sobral, state of CearÃ. A total of 30 leprosy patients were used for the study, before start chemotherapy. The paucibacilary leprosy patient group consisted of eight polar indeterminate, ten polar tuberculÃide, two borderline tuberculÃide, and the multibacilary leprosy patient group consisted of ten lepromatous leprosy and two borderline lepromatous leprosy. The household contacts group consisted of sixty healthy individuals, consanguineous and non consanguineous. The whole M. leprae antigen stimulated IFN-y production in the PBMC of seven borderline tuberculÃide/tuberculÃide (DT/TT), three indeterminate form, two borderline lepromatous/lepromatous (DV/VV the DT/TT group produced IFN-y levels significantly higher than DV/VV group (Fisher Test, p=0,027). The IFN-y production in the household contacts was observed in 34, 21 consanguineous and 13 non consanguineous. It wasnât observed significant difference between paucibacilary householdâs contacts (DT/TT, indeterminate form) and multibacilary householdâs contacts groups in the IFN-y production to whole M. leprae antigen. However, it was observed significant difference in the production of these cytokine between household contacts and DV/VV patients. This study suggests that there wasnât significative difference in the production IFN-y between non consanguineous and consanguineous subjects of the paucibacilary and multibacilary cases. Moreover, at correlacionated the production in these cytokine in the subjects with the presence of scar, we didnât observed significative difference too
APA, Harvard, Vancouver, ISO, and other styles
35

LIPARI, Elisa. "DEVELOPMENT AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DEAMIDATED IFNβ-1a AND INVESTIGATION ABOUT THE MECHANISM OF ACTION." Doctoral thesis, Università degli Studi di Palermo, 2021. http://hdl.handle.net/10447/497430.

Full text
Abstract:
Interferon beta-1a (IFNβ-1a) is a recombinant IFNβ with the tradename Rebif involved in several biological activities. Recently, it has been reported that artificial deamidation of IFNb-1a increases its biological response. Given the therapeutical potential, an investigation on the deamidated variant has been carried out via different approaches to discover the mechanism underlying this biological effect. The antiviral and immunomodulatory activity of deamidated cytokine was assessed using two precise and accurate cell-based assays. As expected, deamidated IFNβ-1a showed an increase in the biological response and its canonical pathway and receptor binding affinity were thorough analysed. Deamidated interferon beta increases STAT1 phosphorylation and ISGs expression compared to its native form. A full in-depth analysis in receptor binding highlighted a change in receptor affinity in deamidated IFNβ-1a. In particular, deamidation destabilizes the interaction with IFNAR2 through a change in the H-bonds network, increasing the affinity to IFNAR1 and consequently to the whole receptor complex. The higher receptor binding and the consequent strong signaling and gene expression, explains the greater biological activity of the deamidated IFNβ-1a compared to the native fcorm. These results open new perspective on the therapeutic potential of this molecule which could have significant beneficial effects on patients with MS and beyond
APA, Harvard, Vancouver, ISO, and other styles
36

Sidwaba, Unathi. "Electrochemical poly(ProDOT) dendritic DNA aptamer biosensor for signalling interferon gamma (IFN-ɣ) TB biomarker." University of the Western Cape, 2017. http://hdl.handle.net/11394/5507.

Full text
Abstract:
Philosophiae Doctor - PhD
Tuberculosis (TB) is an infectious disease that, despite all efforts devoted towards its eradication, remains a threat to many countries including South Africa. Current diagnostic assays do offer better performance than the conventional sputum smear microscopy and tuberculin skin tests. However, these assays have been proven to be affected by various factors including the condition of an individual's immune system and vaccination history. By far, electrochemical biosensors are amongst the currently investigated techniques to address the shortcomings associated with these diagnostics.
2020-08-31
APA, Harvard, Vancouver, ISO, and other styles
37

Schroder, Kate. "Mechanisms of IFN[gamma] priming of macrophage activation by CpG DNA /." [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18684.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Velloso, Álvaro Jorge. "Estudo da infecção pelo TMEV em culturas de células BHK-21 para avaliar a atividade terapêutica do IFN-Β humano na esclerose múltipla." Instituto de Tecnologia em Imunobiológicos, 2009. https://www.arca.fiocruz.br/handle/icict/5827.

Full text
Abstract:
Submitted by Priscila Nascimento (pnascimento@icict.fiocruz.br) on 2012-11-19T17:50:49Z No. of bitstreams: 1 alvaro-jorge-veloso.pdf: 4310180 bytes, checksum: 6e2b4b0375ed58ab1bdd5831f853ac9b (MD5)
Made available in DSpace on 2012-11-19T17:50:49Z (GMT). No. of bitstreams: 1 alvaro-jorge-veloso.pdf: 4310180 bytes, checksum: 6e2b4b0375ed58ab1bdd5831f853ac9b (MD5) Previous issue date: 2009
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Para testar a atividade biológica do interferon beta (INF-β) no tratamento da esclerose múltipla (EM), é importante que se tenha um modelo animal. Como a infecção pelo vírus da encefalomielite murina de Theiler (do inglês TMEV – Theiler’s Murine Encephalomyelitis Vírus) é capaz de evoluir para uma lesão desmielinizantesimilar a da EM em humanos, este estudo se propõe a estabelecer os parâmetros para avaliar a infecção do TMEV em culturas de células de rim de hamster neonato (do inglês BHK-21– Baby hamster kidney cells). Para tanto foi necessário adaptar a amostra viral TMEV BeAn à cultura BHK-21, estabelecer um ensaio de RT-PCR e padronizar um PCR em tempo real.Também foi construido um vetor plasmidial contendo o gen L* do TMEV para expressãotransitoria em células HEK-293-T e esta construção plasmidial foi utilizada para obtenção de um soro policlonal anti-L* utilizando a metodologia de imunização genética. Como resultados foram obtidos estoques virais de células BHK-21 infectadas pelo TMEV e parte destes estoques foram avaliados quanto à presença de moléculas genômica TMEV, indicativa de replicação viral, por ensaios de RT-PCR e quantificação por PCR em tempo real. Asregiões do genoma do TMEV 3A3B e L* foram aquelas que forneceram melhores resultadosnesta avaliação genômica quantitativa, que deverá ser aplicada para todos os estoques TMEVBHK-21 que foram obtidos. O vetor plasmidial de expressão células HEK-293-T pcDNA4His/Max contendo o gene L* expressou com sucesso transitoriamente esta proteína heteróloga, porém não foi capaz de induzir a formação de anticorpos policlonais anti-L* em coelhos, através da técnica de imunização genética.
In order to evaluate the biologic activity of the therapeutic drug beta interferon to multiple sclerosis, an adequate animal model is necessary.inthis aspect the infection of murine encephalomyelitis virus can evolve to desmielinization that is very similar to human’s multiple sclerosis, the proposal of this study was the establishment of parameters to evaluate the TMEV infection in baby hamster kidney cells-BHK-21. Toward that objective was adapted the TMEV BeAn prototype sample to BHK-21 and also was established a RT-PCR and a real time PCR. Additionally, it was constructed a plasmid vector containing the L* gene of TMEV, for the expression in HEK-293-T cells. This plasmid vector was evaluated in the capacity to produce anti-L* antibodies by genetic immunization. It was possible to obtain stocks of BHK-21 TMEV infected and some of these contents were evaluated as of the quantity of genomic molecules of TMEV as an indicative of viral replication, by RT-PCR and real time PCR. The TMEV genomic regions 3A3B and L*provided best results in the quantitative evaluation. In thefuture, the real time PCR could be used to evaluate all the stocks that were produced. The plasmidial vector pcDNA4His/Max containing the L* gene was able to transiently express the L* protein, but unfortunately, it was not able to induce anti-L* in rabbits.
APA, Harvard, Vancouver, ISO, and other styles
39

CARLETTI, TEA. "The Unfolded Protein Response is required early during TBEV infection to trigger the interferon response." Doctoral thesis, Università degli Studi di Trieste, 2016. http://hdl.handle.net/11368/2908030.

Full text
Abstract:
Flaviviruses are a major cause of disease in humans and animals worldwide. Tick-borne encephalitis virus (TBEV) is the most relevant arthropod-borne flavivirus endemic in Europe and is the etiological agent of tick-borne encephalitis, a potentially fatal infection of the central nervous system. In our recent work we demonstrated that TBEV is able to trigger the stress response of infected cells leading to the formation of stress granules (SG) (Albornoz et al. 2014). We also found that the formation of SG in TBEV infected cells is delayed, following the same delayed kinetic of the IFN response (Miorin et al. 2012). Indeed, while TBEV replication is evident at early time points post infection, SG and IFN-β mRNA become detectable only after 16 hours. Transcriptome analysis of TBEV infected cells showed that, in addition to interferon and interferon stimulated genes, also genes of the unfolded protein response (UPR) were activated. Interestingly, the spliced form of XBP1 and phosphorylation of PERK occurred early during infection (<12h) indicating that the UPR occurs before induction of interferon. We then investigated the role of the UPR as an early cellular response to the infection and as a possible trigger of the interferon response. Interestingly, when cells were infected following treatment with Tunicamycin, a known inducer of the UPR, the IFN response was already active at 8 hours post-infection and the virus titres were significantly decreased. In this condition formation of stress granules was also anticipated with the same kinetic. These data suggest that TBEV is able to evade both the stress and interferon responses and that the UPR may play a critical and unexpected role in the delayed activation of both.
APA, Harvard, Vancouver, ISO, and other styles
40

Lauw, Fanny Nadine. "IL-12, IL-18 and IFN-[gamma] in the immune response to bacterial infection." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2000. http://dare.uva.nl/document/82623.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Jesus, Luciano Augusto Oliveira de. "Produção de ifn-y em pacientes com hanseníase e em seus contactantes numa amostra populacional do município de Sobral-Ceará." reponame:Repositório Institucional da UFC, 2007. http://www.repositorio.ufc.br/handle/riufc/1905.

Full text
Abstract:
JESUS, Luciano Augusto Oliveira de. Produção de IFN-Y em pacientes com hanseníase e em seus contactantes numa amostra populacional do município de Sobral-Ceará. 2007. 96 f. Dissertação (Mestrado em Microbiologia Médica) - Universidade Federal do Ceará. Faculdade de Medicina, Fortaleza, 2007.
Submitted by denise santos (denise.santos@ufc.br) on 2012-01-05T13:09:34Z No. of bitstreams: 1 2007_dis_laojesus.pdf: 935043 bytes, checksum: 479087f2722a2585b7c5e90f41bdaeb4 (MD5)
Approved for entry into archive by Eliene Nascimento(elienegvn@hotmail.com) on 2012-02-02T16:26:31Z (GMT) No. of bitstreams: 1 2007_dis_laojesus.pdf: 935043 bytes, checksum: 479087f2722a2585b7c5e90f41bdaeb4 (MD5)
Made available in DSpace on 2012-02-02T16:26:31Z (GMT). No. of bitstreams: 1 2007_dis_laojesus.pdf: 935043 bytes, checksum: 479087f2722a2585b7c5e90f41bdaeb4 (MD5) Previous issue date: 2007
Leprosy, which is caused by Mycobacterium leprae, is an illness of ample clinical and immunopathological spectrum. Its clinical manifestations are correlated with distinct immunologic form, varying from a vigorous immune response mediated by cells to M. leprae, with type 1 standard in the tuberculóide polar region, to an absence of specific cellular response to antigens of M. leprae in the lepromatous polar region, with predominance of type 2 response and exacerbations of humoral response. The capacity of whole M. leprae antigen to stimulate peripheral blood mononuclear cell (PBMC) in the IFN-y production was measured in leprosy patients and their household’s contacts, in the city of Sobral, state of Ceará. A total of 30 leprosy patients were used for the study, before start chemotherapy. The paucibacilary leprosy patient group consisted of eight polar indeterminate, ten polar tuberculóide, two borderline tuberculóide, and the multibacilary leprosy patient group consisted of ten lepromatous leprosy and two borderline lepromatous leprosy. The household contacts group consisted of sixty healthy individuals, consanguineous and non consanguineous. The whole M. leprae antigen stimulated IFN-y production in the PBMC of seven borderline tuberculóide/tuberculóide (DT/TT), three indeterminate form, two borderline lepromatous/lepromatous (DV/VV the DT/TT group produced IFN-y levels significantly higher than DV/VV group (Fisher Test, p=0,027). The IFN-y production in the household contacts was observed in 34, 21 consanguineous and 13 non consanguineous. It wasn’t observed significant difference between paucibacilary household’s contacts (DT/TT, indeterminate form) and multibacilary household’s contacts groups in the IFN-y production to whole M. leprae antigen. However, it was observed significant difference in the production of these cytokine between household contacts and DV/VV patients. This study suggests that there wasn’t significative difference in the production IFN-y between non consanguineous and consanguineous subjects of the paucibacilary and multibacilary cases. Moreover, at correlacionated the production in these cytokine in the subjects with the presence of scar, we didn’t observed significative difference too.
A hanseníase, cujo agente etiológico é o Mycobacterium leprae, é doença de amplo espectro clínico e imunopatológico. Suas apresentações clínicas estão correlacionadas com padrões imunológicos distintos, variando de uma vigorosa resposta imune mediada por células ao M. leprae, com padrão tipo 1 no polo tuberculóide, a uma ausência de resposta celular específica aos antígenos do M. leprae no pólo lepromatoso, com predomínio de resposta tipo 2 e exacerbação da resposta humoral. A capacidade do antígeno bruto de M. leprae em estimular células mononucleares do sangue periférico (PBMC) na produção de IFN-y foi avaliada em pacientes com hanseníase e em seus contactantes, do município de Sobral-CE. Um total de 30 casos foi estudado, antes de receberem tratamento poliquimiterápico. O grupo de casos paucibacilares foi constituído por oito com a forma indeterminada, dez com a forma tuberculóide, dois com a forma dimorfo tuberculóide; e o grupo multibacilar foi constituído por dez com a forma virchoviana e dois com a forma dimorfa virchoviana. O grupo de contactantes foi constituído por sessenta indivíduos, sendo 1 consangüíneo e 1 não consangüíneo para cada caso índice. O antígeno bruto de M. leprae estimulou a produção de IFN-y nas PBMC de sete casos dimorfo tuberculóide/tuberculóide (DT/TT), três com a forma indeterminada e dois com a forma dimorfa virchoviana/virchoviana (DV/VV). O grupo DT/TT produziu níveis de IFN-y significantemente maiores que o grupo DV/VV (Teste de Fisher, p=0,027). A produção de IFN-y nos contactantes foi observada em 34 indivíduos, 21 consangüíneos e 13 não consangüíneos. Não foi observada diferença significativa entre os contactantes do grupo paucibacilar (forma indeterminada, DT/TT) e multibacilares (DV/VV). Porém, foi observada diferença significativa na produção desta citocina entre contactantes e casos DV/VV. O estudo sugere que não há diferença significativa na produção de IFN-y entre indivíduos contactantes consangüíneos e não consangüíneos, dos casos paucibacilares e multibacilares. Além disso, ao correlacionarmos a produção desta citocina nos indivíduos com a presença de cicatriz, também não observamos diferença significativa.
APA, Harvard, Vancouver, ISO, and other styles
42

Sang, Wenjing. "Differential expression of type I interferons in fetal tissues and the maternal-fetal interface in response to PRRSV infection." Thesis, Kansas State University, 2012. http://hdl.handle.net/2097/14183.

Full text
Abstract:
Master of Science
Department of Diagnostic Medicine/Pathobiology
Raymond R. R. Rowland
Interferons (IFNs) comprise a group of antiviral cytokines; however, their expression at the porcine maternal-fetal interface and in fetal tissues has not previously been investigated. The purpose of this study was to analyze the expression of type I IFNs and their receptors in maternal and fetal tissues from sows infected with PRRSV. The approach was to use real-time RT-PCR to identify the expression of different subtypes of type I IFN genes. The results show that the constitutive gene expression of some subtypes including IFN-[alpha] and IFN-[alpha][omega] were detected in fetal lymphoid nodes (IFN-[alpha][omega]), placenta (several IFN-[alpha] subtypes and IFN-[omega]5) and particularly, thymus (multiple IFN-[alpha], IFN-[delta] and IFN-[omega]5). The results demonstrate that porcine type I IFNs are differentially expressed at the maternal-fetal interface and in fetal tissues in response to PRRSV infection.
APA, Harvard, Vancouver, ISO, and other styles
43

Ananthavettivelu, Gevitha [Verfasser], and Gisa [Akademischer Betreuer] Tiegs. "The role of interferon-gamma (IFNγ) in the immune pathogenesis of primary sclerosing cholangitis / Gevitha Ananthavettivelu ; Betreuer: Gisa Tiegs." Hamburg : Staats- und Universitätsbibliothek Hamburg, 2020. http://d-nb.info/121437039X/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Silva, Cláudia Maria de Melo. "Polimorfismos genéticos e associação com a produção de Interferon gama (IFN-γ) em pacientes com Tuberculose pulmonar." Universidade Federal do Amazonas, 2014. http://tede.ufam.edu.br/handle/tede/4766.

Full text
Abstract:
Submitted by Lúcia Brandão (lucia.elaine@live.com) on 2015-12-09T17:42:46Z No. of bitstreams: 1 Dissertação - Cláudia Maria de Melo Silva.pdf: 2215806 bytes, checksum: c9afeecd5c357af061e1b38a8a31df56 (MD5)
Approved for entry into archive by Divisão de Documentação/BC Biblioteca Central (ddbc@ufam.edu.br) on 2016-01-19T19:16:08Z (GMT) No. of bitstreams: 1 Dissertação - Cláudia Maria de Melo Silva.pdf: 2215806 bytes, checksum: c9afeecd5c357af061e1b38a8a31df56 (MD5)
Approved for entry into archive by Divisão de Documentação/BC Biblioteca Central (ddbc@ufam.edu.br) on 2016-01-19T19:17:49Z (GMT) No. of bitstreams: 1 Dissertação - Cláudia Maria de Melo Silva.pdf: 2215806 bytes, checksum: c9afeecd5c357af061e1b38a8a31df56 (MD5)
Made available in DSpace on 2016-01-19T19:17:49Z (GMT). No. of bitstreams: 1 Dissertação - Cláudia Maria de Melo Silva.pdf: 2215806 bytes, checksum: c9afeecd5c357af061e1b38a8a31df56 (MD5) Previous issue date: 2014-04-28
FAPEAM - Fundação de Amparo à Pesquisa do Estado do Amazonas
Tuberculosis (TB) is a chronic infection caused by Mycobacterium tuberculosis complex and remains a major worldwide public health problem, leading to almost 1.45 million deaths annually. The state of Amazonas has a high rate incidence of TB, about 68.3/100,000 inhabitants in 2012. Only 5 to 10% of infected individuals develop active TB. It has been suggested that host factors determine the immune response to pathogen. Thus, many immunogenetic researches have demonstrated TB associated genes, but in the north region, research in this field is still rare. This fact motivated the investigation of polymorphisms for IFNG, IL12B, CD80 and CD86 genes, which codify proteins for cellular immune response. Furthermore, IFN- concentration and its relation with genotypes found have been verified. A total of 177 patients and 224 controls (159 contacts and 65 non-contacts) were included in this study and DNA sequencing was performed for genes IFNG (SNP +874A/T and microsatellite +875), IL12B (SNPs +1030C/T, +1188A/C and +1254T/G), CD80 (SNPs -454 C/A, -387 T/C, -232 G/A, -79 C/G, -7T/C, +5C/A and an indel polymorphism -557_-561insCATGA) and CD86 (SNPs +1057G/A and +1079G/A). The IFN-y concentration was determined by enzyme-linked immunoassay. At IFNG, the presence of the allele +874A and the allele with 15 CA repeats were associated with susceptibility to pulmonary TB, while the allele +874T and the allele with 12 CA repeats were associated with protection from pulmonary TB. In addition, an association between genotype CC (SNP +1188A/C at IL12B) and increased risk of pulmonary TB was found. Furthermore, a significant difference between IFN- concentration and genotypes of SNP +1188A/C at IL12B and microsatellite at IFNG was observed, with decrease of IFN-at genotype CC and 15 CA repeats respectively. These outcomes lead to a better understanding of the immune response regulation for TB and help to determine the genetic profile of the Amazon population. Future researches are still needed for a better understanding of the role of other genes involved in the immune response to M. tuberculosis and their influence at the production of citokines like IFN-.
A Tuberculose (TB) é uma infecção crônica causada pelo complexo Mycobacterium tuberculosis sendo um importante problema de saúde pública mundial, levando a aproximadamente 1,45 milhões de mortes a cada ano. O estado do Amazonas possui uma alta incidência desta doença, atingindo 68,3 casos por 100 mil habitantes em 2012. Dos indivíduos infectados pelo bacilo, cerca de 5 a 10% desenvolvem a Tuberculose ativa, sugerindo que há fatores associados ao hospedeiro que determinam o destino da resposta imune ao patógeno. Neste contexto, diversos estudos em imunogenética têm demonstrado genes associados à TB, mas na região norte ainda são raras as pesquisas nesta área, fato que motivou a investigação da frequência dos polimorfismos nos genes IFNG, IL12B, CD80 e CD86, que codificam para proteínas fundamentais na resposta imune celular. Além disso, foi verificado se a concentração de IFN- está relacionada com o genótipo encontrado. Foram incluídas amostras de 177 pacientes e 224 controles (159 contatos e 65 não contatos) e realizado sequenciamento de DNA para os genes IFNG (SNP +874A/T e microssatélite +875), IL12B (SNPs +1030C/T, +1188A/C e +1254T/G), CD80 (SNPs -454 C/A, -387 T/C, -232 G/A, -79 C/G, -7T/C e +5C/A e um polimorfismo indel -557_-561insCATGA) e CD86 (SNPs +1057G/A e +1079G/A). A determinação das concentrações de IFN-foi realizada através de ensaio imunoenzimático. Foi verificada uma associação do gene IFNG, entre a presença do alelo +874A e 15 repetições CA, como fator de risco para TB pulmonar assim como a presença do alelo +874T e 12 repetições CA como fatores de proteção contra TB pulmonar. Também foi encontrada uma associação do genótipo CC, do SNP +1188A/C no gene IL12B, como fator de risco ao desenvolvimento da TB pulmonar. Houve diferença significativa na concentração de IFN-entre os genótipos do SNP +1188A/C no gene IL12B e o microssatélite no gene IFNG, com menor produção no genótipo CC e 15 repetições CA respectivamente. Estes resultados contribuem para o melhor entendimento da regulação na resposta imune à TB e auxilia na determinação do perfil genético da população da região Amazônica. Estudos futuros são necessários para uma melhor compreensão do papel de outros genes envolvidos na resposta imunológica a M. tuberculosis e influência nos níveis de produção de citocinas como IFN-.
APA, Harvard, Vancouver, ISO, and other styles
45

Curtis, Rachael E. "Distribution of Cellular Interferon Beta (IFN-β) in Murine Fibroblast Cell Lines Upon Infection of HSV-1." Wright State University / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=wright1323805692.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Nakamura, Tetsuo. "Expression of Glycosylated Human Interferon-beta (IFN-β) in High Levels in Chinese Hamster Ovary (CHO) Cells." Kyoto University, 2000. http://hdl.handle.net/2433/151588.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Gray, Reginald Courtney. "Regulation of Interferon Alpha Beta Induction and Dendritic Cell Function by CpG Oligodeoxynucleotides." Case Western Reserve University School of Graduate Studies / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=case1186014244.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Pulit-Penaloza, Joanna A. "Regulation of Interferon Stimulated Genes in West Nile Virus Infected Mouse Embryofibroblasts." Digital Archive @ GSU, 2012. http://digitalarchive.gsu.edu/biology_diss/110.

Full text
Abstract:
The induction of type I interferon (IFN) and subsequent activation of interferon stimulated genes (ISGs) represent a first line of defense against viral infection. Typically type I IFN signaling leads to the phosphorylation of the STAT1 and STAT2 transcription factors (TFs) which then form a trimetric complex with IRF-9 and translocate to the nucleus to induce ISG expression. However, the results of this study showed that IFN-mediated upregulation of the ISG Oas1b, the product of which confers resistance to flavivirus induced disease, can be induced in a STAT1-independent manner. Since numerous ISGs have antiviral functions, many viruses have evolved strategies to disrupt the type I IFN-signaling pathway. In cases when STAT1 activation is blocked by a viral infection, STAT1-independent upregulation of ISGs provides an additional strategy for the cell to mount an effective antiviral response. Infection of mouse embryofibroblasts (MEFs) with West Nile virus (WNV) induced the production of IFN beta and STAT1 and STAT2 phosphorylation but blocked nuclear translocation and binding of these TFs to the promoters of the ISGs, Oas1a, Oas1a, Irf7 and Irf1. However, each of these antiviral ISGs was efficiently upregulated in infected cells and IRF-9 was shown to be crucial for the upregulation of Oas1a, Oas1b and Irf-7. IRF-3 or IRF-7 was needed to maintain the upregulation of these genes at later times of infection. In contrast, the upregulation of Irf1 by WNV infection did not depend on the tested IRFs but was reduced by inhibition of the p38 or NF-kappa B pathways. Although Irf1 mRNA was efficiently upregulated in WNV-infected cells IRF-1 protein synthesis was blocked. The precise mechanism of the IRF-1 translational suppression is not yet known, but the suppression was shown not to be due to increased proteasomal degradation of IRF-1 nor to alternative splicing of Irf1 mRNA. Preliminary results suggest miRNAs may play an indirect role in regulating IRF-1 translation. The results of this study expand knowledge about the strategies evolved by viruses to evade host cell antiviral responses and also provide valuable insights about alternative mechanisms utilized by the host cell to counteract viral infections.
APA, Harvard, Vancouver, ISO, and other styles
49

Raices, Raquel Marie. "A novel role for Il-1 cytokines and Tnf[alpha] in Ifn[gamma] production, which is mediated by I[kappa]b[zeta]." Columbus, Ohio : Ohio State University, 2008. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1211994580.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

LA, SORSA VALENTINA. "Role of type I IFN in the in vitro differentiation of neonatal dendritic cells." Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2009. http://hdl.handle.net/2108/1057.

Full text
Abstract:
Negli ultimi anni numerose pubblicazioni hanno evidenziato l’influenza che l’IFN di tipo I esercita sul differenziamento, sulla sopravvivenza e sulla funzionalità delle cellule dendritiche e dei linfociti T; in particolare è stato dimostrato l’IFN/ è in grado di indurre in vitro un rapido differenziamento di monociti da sangue periferico in cellule dendritiche particolarmente efficienti nella stimolazione di linfociti T e B (Santini, Lapenta et al. 2000; Honda, Sakaguchi et al. 2003). In questo lavoro abbiamo studiato il ruolo che L’IFN di tipo I riveste sul differenziamento e sulla funzionalità delle cellule dendritiche neonatali. Monociti da sangue di cordone ombelicale sono stati coltivati in vitro in presenza di GM-CSF ed interleuchina 4 (IL4) oppure GM-CSF ed IFN, le cellule dendritiche così ottenute sono state caratterizzate per fenotipo ed attività funzionale. I risultati sono stati paragonati- laddove possibile- con quelli ottenuti dai monociti di sangue periferico. Lo stesso protocollo di coltura in vitro con IFN è stato applicato ai precursori midollari delle cellule dendritiche isolati da topi C57BL6, sempre allo scopo di valutare l’influenza dell’ IFN di tipo I sul loro differenziamento e/o sulla loro maturazione. L’analisi fenotipica delle cellule dendritiche da cordone differenziate con IFN ha evidenziato un fenotipo tipico di cellule immature che esprimono bassi livelli di molecole costimolatorie come CD80 e CD86. Il differenziamento di monociti neonatali in presenza di IL4 ha evidenziato un maggiore grado di immaturità rispetto alla controparte adulta, soprattutto legato ad una espressione ridotta di CD40,CD80 ed HLA-DR. Questi dati sono in accordo con la letteratura corrente, sebbene sia da evidenziare che nel caso di monociti neonatali l’IFN promuove il differenziamento in dendritiche in misura maggiore rispetto al protocollo classico con IL4.D’altra parte monociti provenienti da periferico differenziati in presenza di IFN mostrano un fenotipo semi maturo caratterizzato da una espressione di CD40, CD80, CD86 ed HLA-DR superiore rispetto ai monociti da periferico differenziati in presenza di IL4. I monociti da sangue di cordone risultano essere meno sensibili all’azione dell’IFN rispetto ai monociti da periferico. L’analisi del livello di espressione delle due catene del recettore per l’IFN, IFNAR1 ed IFNAR2, ha rivelato che esiste una modulazione dell’espressione sulla superficie cellulare durante il differenziamento in vitro. Questa modulazione è del tutto sovrapponibile nei monociti da cordone e in quelli da periferico. Allo stesso modo il raffronto fra la percentuale di STAT1 fosforilata rispetto a STAT1, nei monociti neonatali ed adulti , in seguito a stimolazione con IFN, ha dato risultati simili, che si attestano tra valori del 75% e 90% senza evidenziare alcuna differenza per quanto riguarda l’attivazione delle prime fasi del signalling fra cellule adulte e neonatali. Poiché le cellule dendritiche nella loro forma immatura sono in grado di riconoscere gli antigeni mediante recettori di superficie chiamati toll-like receptors, la presenza di questi recettori è stata studiata nei monociti da cordone e da sangue periferico. I monociti da periferico e da cordone esprimono entrambi i TLR2 e TLR4 ma non il TLR3. Inoltre i monociti da cordone esprimono il TLR4 in misura inferiore. Il TLR2 è il recettore per i peptidoglicani mentre il TLR4 è il recettore per il lipopolisaccaride (LPS), entrambi di origine batterica. Da un punto di vista strettamente funzionale i monociti e le dendritiche da cordone non rispondono alla stimolazione in vitro con LPS, che invece costituisce un potente stimolo maturativo insieme al CD40L per monociti e dendritiche da periferico. La capacità delle dendritiche neonatali differenziate con IFN di indurre la proliferazione di linfociti CD4+ e CD8+ da sangue periferico adulto è inferiore rispetto a quella delle dendritiche da cordone differenziate con il protocollo classico. Al contrario dendritiche ottenute in presenza di IFN a partire da cellule del periferico hanno una maggiore capacita allostimolatoria rispetto a quelle derivate in vitro con IL4. Cellule dendritiche da periferico differenziate con entrambi i protocolli mostrano di possedere le stesse attività di endocitosi e macropinocitosi come dimostrato da analisi mediante citofluorimetria dell’uptake con l’utilizzo di antigeni marcati. Per contro dendritiche da cordone differenziate con IFN risultamo meno efficienti nell’endocitare l’antigene rispetto alle dendritiche da cordone differenziate con IL4. Nel modello murino i precursori midollari delle dendritiche di topo sono stati coltivati in vitro in presenza diGMCSF e poi stimolati con IFN, LPS ed HBHA. Quest’ultimo antigene è una emoagglutinina responsabile della disseminazione extrapolmonare del bacillo della tubercolosi. In questo caso l’IFN non si è dimostrato superiore agli altri stimoli nel promuovere la maturazione dei precursori midollari in dendritiche , ma ha dimostrato di avere un effetto sinergico se somministrato in combinazione con l’HBHA, aumentando sensibilmente l’espressione della classe I sulla superficie cellulare. In compenso, in saggi funzionali, le cellule dendritiche stimolate con IFN sono state i più efficaci induttori di proliferazione di splenociti di topo CD4+ e CD8+. E’ stato recentemente dimostrato che un trattamento acuto con l’IFN di classe I è capace di promuovere la proliferazione in vivo di progenitori ematopoietici staminali , mentre la somministrazione continuativa di IFN inibisce i processi di rigenerazione del pool dei progenitori stessi. Si può dunque ipotizzare che l’IFN possa sortire effetti diversi sulle cellule target in funzione del dosaggio e del tipo di somministrazione che viene utilizzato. Pertanto ulteriori studi sono necessari al fine di determinare in modo più dettagliato e conclusivo quale sia l’effetto di questa citochina nel delicato equilibrio che regola la risposta immune nei neonati.
In recent years, a number of reports provided evidence on the importance of type I IFNs in the differentiation, survival and function of several cell types including T cells and dendritic cells (DCs) (Brassard, Grace et al. 2002). IFN-/ has been shown to promote the rapid differentiation of GM-CSF-treated human peripheral blood monocytes into DCs with potent T cell and B cell stimulatory activities (Santini, Lapenta et al. 2000; Honda, Sakaguchi et al. 2003). These results have led to the suggestion that IFN-I could also play a role in the maturation/differentiation of neonatal DCs and in the modulation of Th-1 response which is impaired in neonates. Aim. In this study we focused on DC from umbilical cord blood, as these are the coordinators of the innate as well as the specific immune response, and on the role of type I IFN in their in vitro differentiation/maturation starting from neonatal monocytes. In particular cord blood-derived monocytic cells were cultured in vitro in the presence of GM-CSF and IL-4 or, alternatively, GM-CSF and IFN-α. DCs obtained by the two different methods were analysed in terms of phenotype and functional activity. Wherever possible results from neonatal cord blood-derived DCs were compared with adult peripheral blood-derived DCs. In the mouse model, namely C57BL6 mice, we studied the role of IFN α – in the in vitro differentiation and maturation of bone marrow DC precursors from neonatal mice. Results. Cord blood DCs differentiated in vitro in the presence of IFN were found to have an immature phenotype as they express low levels of costimulatory molecules such as CD80 and CD86. Similar observations were made when neonatal monocytes were cultured in the presence of GM-CSF and IL4 as they displayed reduced HLADR, CD80 and CD40 expression compared to the adult counterparts. Of note, IFN induced differentiation in neonatal cells was still superior to IL4 induced differentiation. No significant differences between cord blood and peripheral blood monocytes were found in the IFN receptor expression during their in vitro differentiation into DCs. The analysis of STAT1, which is the most proximal target of the IFN receptor-associated tyrosine kinases, revealed that a marked tyrosine phosphorylation of STAT1 was observed both in neonatal and adult monocytes at a comparable level ranging from 75% to 90%. DCs in their immature form recognise conserved molecular motifs found in microrganisms by means of pattern-recognition receptors called toll-like receptors (TLRs). The expression pattern of TLRs in IFN-DCs and IL4-DCs have been compared. All monocytes from both peripheral blood (PB) and cord blood (CB) samples expressed TLR-2 and TLR-4 but not TLR-3. Despite the comparable frequencies of monocytes expressing TLR-4, those from cord blood expressed lower amounts of TLR-4 than those from peripheral blood (p < 0.05). From a functional point of view cord blood untreated monocytes and IFN treated DCs showed a deficiency in their ability to respond to LPS and T cell proliferation responses induced by this cells were lower with respect to the peripheral blood counterparts. .Moreover while the majority of PBDCs , either differentiated by IL4 or by IFN, retained comparable phagocytic and processing activity, cord blood IFN-DCs showed a less efficient antigen uptake with respect to the CB IL4-DCs in terms of mannose receptor-mediated endocytosis. Mouse bone marrow derived DCs precursors were coltured in vitro with IFNα alone or in combination with the HBHA (heparin binding haemoagglutinin, a mycobacterial adhesin) antigen and LPS. IFNα treatment proved to be similar to HBHA and LPS stimulation in terms of CD40, CD86 and Class II expression, only the combination of HBHA plus IFNα enhanced DC maturation expecially for Class I expression. The analysis of percentage of mature cells after the stimulation confirmed that IFN alone was not superior to the other stimuli, but it appeared that neonatal bone marrow DCs treated with IFNα, were more efficient inducers of CD4+ and CD8+ mouse lymphocytes proliferation. Conclusions. It is conceivable that IFN can exert opposite effects depending on the timing and the cells differentiation stage, for example by selectively enhancing functional activity at the stage of maturing DCs but exerting an inhibitory effect on DC functions when given at early stages of differentiation. In particular it has been demonstrated that short term IFN stimulation promotes the proliferation of dormant haematopoietic stem cells in vivo whereas chronic IFN treatment exert inhibitory effects on HSC self renewal. Further studies are needed to understand the differential roles that Type I IFN may play in affecting DC function and shaping the immune response in the neonatal environment.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!